Laboratory assays for total cholesterol, high - density lipoprotein ( HDL) cholesterol, low - density lipoprotein ( LDL) cholesterol, triglycerides, glucose, C - reactive protein ( CRP ), interleukin 6 ( IL - 6 ), and insulin were described previously [ 22 ].	"cholesterol	28	39	Chemical/Drug"	"cholesterol	75	86	Chemical/Drug"	"cholesterol	121	132	Chemical/Drug"	"triglycerides	134	147	Chemical/Drug"	"glucose	149	156	Chemical/Drug"	"C - reactive protein	158	178	Gene/Protein"	"CRP	181	184	Gene/Protein"	"interleukin 6	188	201	Gene/Protein"	"IL - 6	204	210	Gene/Protein"	"insulin	218	225	Gene/Protein"	"[{""token"": ""cholesterol"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Chemical/Drug""}, {""token"": ""triglycerides"", ""start_span"": 134, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""glucose"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Chemical/Drug""}, {""token"": ""C - reactive protein"", ""start_span"": 158, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""CRP"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 6"", ""start_span"": 188, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 204, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""insulin"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Gene/Protein""}]"
When participants were characterized according to amylin quartiles ( Table 2 ), persons in the higher amylin quartile had significantly higher levels of BMI, waist circumference, blood pressure, fasting glucose, insulin, HOMA - IR, amylin / insulin ratio, total and LDL cholesterol, triglycerides, but lower HDL cholesterol concentrations ( all P < 0. 001) compared with those in the lower quartile.	"amylin	50	56	Gene/Protein"	"amylin	102	108	Gene/Protein"	"glucose	203	210	Chemical/Drug"	"insulin	212	219	Gene/Protein"	"IR	228	230	Disease/Disorder"	"amylin	232	238	Gene/Protein"	"insulin	241	248	Gene/Protein"	"cholesterol	270	281	Chemical/Drug"	"triglycerides	283	296	Chemical/Drug"	"cholesterol	312	323	Chemical/Drug"	"[{""token"": ""amylin"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""amylin"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""glucose"", ""start_span"": 203, ""end_span"": 210, ""type"": ""Chemical/Drug""}, {""token"": ""insulin"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""IR"", ""start_span"": 228, ""end_span"": 230, ""type"": ""Disease/Disorder""}, {""token"": ""amylin"", ""start_span"": 232, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""insulin"", ""start_span"": 241, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""cholesterol"", ""start_span"": 270, ""end_span"": 281, ""type"": ""Chemical/Drug""}, {""token"": ""triglycerides"", ""start_span"": 283, ""end_span"": 296, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 312, ""end_span"": 323, ""type"": ""Chemical/Drug""}]"
Amylin was positively correlated with BMI, waist circumference, blood pressure, fasting glucose, insulin, HOMA - IR, total cholesterol, LDL - cholesterol, triglycerides, inflammatory markers of CRP and IL - 6, while, negatively correlated with plasma HDL - cholesterol ( Table 3, all P < 0. 001 ), after adjustment for age and sex.	"Amylin	0	6	Gene/Protein"	"glucose	88	95	Chemical/Drug"	"insulin	97	104	Gene/Protein"	"IR	113	115	Disease/Disorder"	"cholesterol	123	134	Chemical/Drug"	"cholesterol	142	153	Chemical/Drug"	"triglycerides	155	168	Chemical/Drug"	"CRP	194	197	Gene/Protein"	"IL - 6	202	208	Gene/Protein"	"cholesterol	257	268	Chemical/Drug"	"[{""token"": ""Amylin"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""glucose"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""insulin"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IR"", ""start_span"": 113, ""end_span"": 115, ""type"": ""Disease/Disorder""}, {""token"": ""cholesterol"", ""start_span"": 123, ""end_span"": 134, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 142, ""end_span"": 153, ""type"": ""Chemical/Drug""}, {""token"": ""triglycerides"", ""start_span"": 155, ""end_span"": 168, ""type"": ""Chemical/Drug""}, {""token"": ""CRP"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 202, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""cholesterol"", ""start_span"": 257, ""end_span"": 268, ""type"": ""Chemical/Drug""}]"
In spite of the greater diversity of NMDAR subunits in chordates, homology of Grin1 and Grin2 across bilaterian animals suggests that a wealth of discovery in the mechanisms of NMDAR - induced plasticity is nevertheless possible in simpler nervous systems such as Aplysia, with relevance to vertebrate NMDAR physiology, including that of humans.	"NMDAR	37	42	Gene/Protein"	"chordates	55	64	Organism/Species"	"Grin1	78	83	Gene/Protein"	"Grin2	88	93	Gene/Protein"	"animals	112	119	Organism/Species"	"NMDAR	177	182	Gene/Protein"	"Aplysia	264	271	Organism/Species"	"vertebrate	291	301	Organism/Species"	"NMDAR	302	307	Gene/Protein"	"humans	338	344	Organism/Species"	"[{""token"": ""NMDAR"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""chordates"", ""start_span"": 55, ""end_span"": 64, ""type"": ""Organism/Species""}, {""token"": ""Grin1"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""Grin2"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""animals"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""NMDAR"", ""start_span"": 177, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""Aplysia"", ""start_span"": 264, ""end_span"": 271, ""type"": ""Organism/Species""}, {""token"": ""vertebrate"", ""start_span"": 291, ""end_span"": 301, ""type"": ""Organism/Species""}, {""token"": ""NMDAR"", ""start_span"": 302, ""end_span"": 307, ""type"": ""Gene/Protein""}, {""token"": ""humans"", ""start_span"": 338, ""end_span"": 344, ""type"": ""Organism/Species""}]"
Confocal imaging of CP - GFP, GFP - CP, CP - RFP, and RFP - CP in N. benthamiana epidermal cells was performed on a Leica TCS SP8 point scanning confocal microscope using the pre - set settings for GFP ( with Ex: 488 nm, Em: 500 – 550 nm) or for RFP ( with Ex: 561 nm, Em: 600 – 650 nm ).	"CP	20	22	Gene/Protein"	"GFP	25	28	Gene/Protein"	"GFP	30	33	Gene/Protein"	"CP	36	38	Gene/Protein"	"CP	40	42	Gene/Protein"	"RFP	45	48	Gene/Protein"	"RFP	54	57	Gene/Protein"	"CP	60	62	Gene/Protein"	"GFP	198	201	Gene/Protein"	"RFP	246	249	Gene/Protein"	"[{""token"": ""CP"", ""start_span"": 20, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 36, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 40, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""RFP"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""RFP"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 60, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""RFP"", ""start_span"": 246, ""end_span"": 249, ""type"": ""Gene/Protein""}]"
Stage I: GFP - fused CP localizes strongly to the nucleolus and more weakly to the nucleoplasm, and only occasionally forms a few speckles in a few cells (< 5 %); Stage II: GFP - fused CP shows a similar localization similar to that of Stage I, but forms numerous speckles in the nucleoplasm; Stage III: GFP - fused CP shows a localization similar to that of Stage II, but it is absent from the nucleolus; Stage IV: GFP - fused CP localizes to the nucleoplasm only, where it is unevenly distributed; Stage V: GFP - fused CP is uniformly distributed in the nucleoplasm.	"GFP	9	12	Gene/Protein"	"CP	21	23	Gene/Protein"	"GFP	173	176	Gene/Protein"	"CP	185	187	Gene/Protein"	"GFP	304	307	Gene/Protein"	"CP	316	318	Gene/Protein"	"GFP	416	419	Gene/Protein"	"CP	428	430	Gene/Protein"	"GFP	509	512	Gene/Protein"	"CP	521	523	Gene/Protein"	"[{""token"": ""GFP"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 21, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 185, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 304, ""end_span"": 307, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 316, ""end_span"": 318, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 416, ""end_span"": 419, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 428, ""end_span"": 430, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 509, ""end_span"": 512, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 521, ""end_span"": 523, ""type"": ""Gene/Protein""}]"
Bone marrow cells were lineage depleted by incubating with the following rat anti mouse lineage antibodies: CD4 ( clone GK1. 5 ), CD8a ( 53 - 6. 7 ), B220 ( RA3 - 6B2 ), Gr - 1 ( RB6 - 8C5 ), Mac - 1 ( M1 / 70 ), Ter119 ( Ter - 119 ).	"rat	73	76	Organism/Species"	"mouse	82	87	Organism/Species"	"antibodies	96	106	Gene/Protein"	"CD4	108	111	Gene/Protein"	"CD8a	130	134	Gene/Protein"	"B220	150	154	Gene/Protein"	"Gr - 1	170	176	Gene/Protein"	"Mac - 1	192	199	Gene/Protein"	"Ter119	213	219	Gene/Protein"	"Ter - 119	222	231	Gene/Protein"	"[{""token"": ""rat"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Organism/Species""}, {""token"": ""antibodies"", ""start_span"": 96, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""CD8a"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""B220"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""Gr - 1"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""Mac - 1"", ""start_span"": 192, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""Ter119"", ""start_span"": 213, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""Ter - 119"", ""start_span"": 222, ""end_span"": 231, ""type"": ""Gene/Protein""}]"
Microarray analysis also showed many differentially expressed transcription factors ( TFs) such as Myc, Jun, Stat3 and Smad1 were up - regulated, whereas Sip1, Hnf1α, Hnf4α and Glis2 were down - regulated in diseased kidneys.	"transcription factors	62	83	Gene/Protein"	"TFs	86	89	Gene/Protein"	"Myc	99	102	Gene/Protein"	"Jun	104	107	Gene/Protein"	"Stat3	109	114	Gene/Protein"	"Smad1	119	124	Gene/Protein"	"Sip1	154	158	Gene/Protein"	"Hnf1α	160	165	Gene/Protein"	"Hnf4α	167	172	Gene/Protein"	"Glis2	177	182	Gene/Protein"	"[{""token"": ""transcription factors"", ""start_span"": 62, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""TFs"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""Myc"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Smad1"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""Sip1"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""Hnf1\u03b1"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""Hnf4\u03b1"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""Glis2"", ""start_span"": 177, ""end_span"": 182, ""type"": ""Gene/Protein""}]"
In addition, several other risk factors include primary sclerosing cholangitis, hepatolithiasis, choledochal cysts, primary biliary cirrhosis, parasitic biliary infection with Clonorchis sinensis or Opisthorchis viverrini, inflammatory bowel disease, and chronic pancreatitis [ 14 ], as well as the historical use of the radiologic contrast agent Thorotrast.	"primary sclerosing cholangitis	48	78	Disease/Disorder"	"hepatolithiasis	80	95	Disease/Disorder"	"choledochal cysts	97	114	Disease/Disorder"	"primary biliary cirrhosis	116	141	Disease/Disorder"	"parasitic biliary infection	143	170	Disease/Disorder"	"Clonorchis sinensis	176	195	Organism/Species"	"Opisthorchis viverrini	199	221	Organism/Species"	"inflammatory bowel disease	223	249	Disease/Disorder"	"chronic pancreatitis	255	275	Disease/Disorder"	"Thorotrast	347	357	Chemical/Drug"	"[{""token"": ""primary sclerosing cholangitis"", ""start_span"": 48, ""end_span"": 78, ""type"": ""Disease/Disorder""}, {""token"": ""hepatolithiasis"", ""start_span"": 80, ""end_span"": 95, ""type"": ""Disease/Disorder""}, {""token"": ""choledochal cysts"", ""start_span"": 97, ""end_span"": 114, ""type"": ""Disease/Disorder""}, {""token"": ""primary biliary cirrhosis"", ""start_span"": 116, ""end_span"": 141, ""type"": ""Disease/Disorder""}, {""token"": ""parasitic biliary infection"", ""start_span"": 143, ""end_span"": 170, ""type"": ""Disease/Disorder""}, {""token"": ""Clonorchis sinensis"", ""start_span"": 176, ""end_span"": 195, ""type"": ""Organism/Species""}, {""token"": ""Opisthorchis viverrini"", ""start_span"": 199, ""end_span"": 221, ""type"": ""Organism/Species""}, {""token"": ""inflammatory bowel disease"", ""start_span"": 223, ""end_span"": 249, ""type"": ""Disease/Disorder""}, {""token"": ""chronic pancreatitis"", ""start_span"": 255, ""end_span"": 275, ""type"": ""Disease/Disorder""}, {""token"": ""Thorotrast"", ""start_span"": 347, ""end_span"": 357, ""type"": ""Chemical/Drug""}]"
Some immunohistochemical markers, including CK7, CK20, CDX - 2, TTF - 1, ER, PR, BRST - 2, AFP, CEA, CA19 - 9, and PSA, may help to exclude common primary sites including colon, lung, breast, and prostate [ 29 ].	"CK7	44	47	Gene/Protein"	"CK20	49	53	Gene/Protein"	"CDX - 2	55	62	Gene/Protein"	"TTF - 1	64	71	Gene/Protein"	"ER	73	75	Gene/Protein"	"PR	77	79	Gene/Protein"	"BRST - 2	81	89	Gene/Protein"	"AFP	91	94	Gene/Protein"	"CEA	96	99	Gene/Protein"	"PSA	115	118	Gene/Protein"	"[{""token"": ""CK7"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""CK20"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""CDX - 2"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""TTF - 1"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""ER"", ""start_span"": 73, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""PR"", ""start_span"": 77, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""BRST - 2"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""AFP"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CEA"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""PSA"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}]"
To study the effect of MomL on pectate lyase expression, four related genes ( pectate lyase gene pel, pectate lyase precursor 1 gene pelp1, pectate lyase precursor 2 gene pelp2 and pectin lyase regulator gene pelr) were detected by real - time PCR.	"MomL	23	27	Gene/Protein"	"pectate lyase	31	44	Gene/Protein"	"pectate lyase	78	91	Gene/Protein"	"pel	97	100	Gene/Protein"	"pectate lyase precursor 1	102	127	Gene/Protein"	"pelp1	133	138	Gene/Protein"	"pectate lyase precursor 2	140	165	Gene/Protein"	"pelp2	171	176	Gene/Protein"	"pectin lyase regulator	181	203	Gene/Protein"	"pelr	209	213	Gene/Protein"	"[{""token"": ""MomL"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""pectate lyase"", ""start_span"": 31, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""pectate lyase"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""pel"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""pectate lyase precursor 1"", ""start_span"": 102, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""pelp1"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""pectate lyase precursor 2"", ""start_span"": 140, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""pelp2"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""pectin lyase regulator"", ""start_span"": 181, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""pelr"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Gene/Protein""}]"
In HEK 482T, substrate compounds, such as Caffeine, Diltiazem, Epinephrine, Estradiol, Raloxifene and Verapamil, did not significantly affect the uptake rate of Mitoxantrone, whereas in both 482R and 482G, substrate compounds, such as Foscarnet and Rhodamine 123, did not significantly affect the uptake rate of Mitoxantrone.	"Caffeine	42	50	Chemical/Drug"	"Diltiazem	52	61	Chemical/Drug"	"Epinephrine	63	74	Chemical/Drug"	"Estradiol	76	85	Chemical/Drug"	"Raloxifene	87	97	Chemical/Drug"	"Verapamil	102	111	Chemical/Drug"	"Mitoxantrone	161	173	Chemical/Drug"	"Foscarnet	235	244	Chemical/Drug"	"Rhodamine 123	249	262	Chemical/Drug"	"Mitoxantrone	312	324	Chemical/Drug"	"[{""token"": ""Caffeine"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Chemical/Drug""}, {""token"": ""Diltiazem"", ""start_span"": 52, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""Epinephrine"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""Estradiol"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""Raloxifene"", ""start_span"": 87, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""Verapamil"", ""start_span"": 102, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""Mitoxantrone"", ""start_span"": 161, ""end_span"": 173, ""type"": ""Chemical/Drug""}, {""token"": ""Foscarnet"", ""start_span"": 235, ""end_span"": 244, ""type"": ""Chemical/Drug""}, {""token"": ""Rhodamine 123"", ""start_span"": 249, ""end_span"": 262, ""type"": ""Chemical/Drug""}, {""token"": ""Mitoxantrone"", ""start_span"": 312, ""end_span"": 324, ""type"": ""Chemical/Drug""}]"
Lineage positive cell types were purified without lineage depletion using the following antibodies: B cells ( B220 - PE ), T cells ( CD3 - PE ), Macrophages ( Gr1 - PE, CD11b - FITC ), Granulocytes ( 7 / 4 - PE, Gr1 - FITC ).	"antibodies	88	98	Gene/Protein"	"B220	110	114	Gene/Protein"	"PE	117	119	Gene/Protein"	"CD3	133	136	Gene/Protein"	"PE	139	141	Gene/Protein"	"Gr1	159	162	Gene/Protein"	"PE	165	167	Gene/Protein"	"CD11b	169	174	Gene/Protein"	"PE	208	210	Gene/Protein"	"Gr1	212	215	Gene/Protein"	"[{""token"": ""antibodies"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""B220"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""PE"", ""start_span"": 117, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""PE"", ""start_span"": 139, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""Gr1"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""PE"", ""start_span"": 165, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""PE"", ""start_span"": 208, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""Gr1"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene/Protein""}]"
To test whether pre - exposure of rMjGal to a galectin carbohydrate ligand could prevent the binding of rMjGal to the bacteria, the purified rMjGal ( 500 µg / ml) was pre - incubated with lactose ( a typical galectin ligand) or glucose ( as the negative control ), and the bacteria were added, incubated for 1 h, washed, and the bound proteins eluted with 7% SDS.	"rMjGal	34	40	Gene/Protein"	"galectin	46	54	Gene/Protein"	"carbohydrate	55	67	Chemical/Drug"	"rMjGal	104	110	Gene/Protein"	"bacteria	118	126	Organism/Species"	"rMjGal	141	147	Gene/Protein"	"lactose	188	195	Chemical/Drug"	"galectin	208	216	Gene/Protein"	"glucose	228	235	Chemical/Drug"	"bacteria	273	281	Organism/Species"	"[{""token"": ""rMjGal"", ""start_span"": 34, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""galectin"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""carbohydrate"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""rMjGal"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Organism/Species""}, {""token"": ""rMjGal"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""lactose"", ""start_span"": 188, ""end_span"": 195, ""type"": ""Chemical/Drug""}, {""token"": ""galectin"", ""start_span"": 208, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""glucose"", ""start_span"": 228, ""end_span"": 235, ""type"": ""Chemical/Drug""}, {""token"": ""bacteria"", ""start_span"": 273, ""end_span"": 281, ""type"": ""Organism/Species""}]"
This pathway has critical roles in normal brain function, as abnormalities in the expression and / or activity of its upstream and downstream components have been identified in numerous neurodevelopmental and neuropsychiatric disorders, including autism spectrum disorders ( ASDs ), drug addiction, intellectual disability ( ID ), major depressive disorder ( MDD ), and schizophrenia ( SCZ; Costa - Mattioli and Monteggia, 2013 ).	"neuropsychiatric disorders	209	235	Disease/Disorder"	"autism spectrum disorders	247	272	Disease/Disorder"	"ASDs	275	279	Disease/Disorder"	"drug addiction	283	297	Disease/Disorder"	"intellectual disability	299	322	Disease/Disorder"	"ID	325	327	Disease/Disorder"	"major depressive disorder	331	356	Disease/Disorder"	"MDD	359	362	Disease/Disorder"	"schizophrenia	370	383	Disease/Disorder"	"SCZ	386	389	Disease/Disorder"	"[{""token"": ""neuropsychiatric disorders"", ""start_span"": 209, ""end_span"": 235, ""type"": ""Disease/Disorder""}, {""token"": ""autism spectrum disorders"", ""start_span"": 247, ""end_span"": 272, ""type"": ""Disease/Disorder""}, {""token"": ""ASDs"", ""start_span"": 275, ""end_span"": 279, ""type"": ""Disease/Disorder""}, {""token"": ""drug addiction"", ""start_span"": 283, ""end_span"": 297, ""type"": ""Disease/Disorder""}, {""token"": ""intellectual disability"", ""start_span"": 299, ""end_span"": 322, ""type"": ""Disease/Disorder""}, {""token"": ""ID"", ""start_span"": 325, ""end_span"": 327, ""type"": ""Disease/Disorder""}, {""token"": ""major depressive disorder"", ""start_span"": 331, ""end_span"": 356, ""type"": ""Disease/Disorder""}, {""token"": ""MDD"", ""start_span"": 359, ""end_span"": 362, ""type"": ""Disease/Disorder""}, {""token"": ""schizophrenia"", ""start_span"": 370, ""end_span"": 383, ""type"": ""Disease/Disorder""}, {""token"": ""SCZ"", ""start_span"": 386, ""end_span"": 389, ""type"": ""Disease/Disorder""}]"
Notably, several studies investigating Shank3 knock - out ( KO) mice and Shank3 knock - down in neurons revealed that the loss of Shank3 expression results in changes of specific signaling pathways such as metabotropic glutamate receptor 5 ( mGluR5) signaling ( Verpelli et al ., 2011; Wang et al ., 2016; Vicidomini et al ., 2017 ), and protein kinase B ( PKB / Akt )- mTOR signaling ( Bidinosti et al ., 2016 ).	"Shank3	39	45	Gene/Protein"	"mice	64	68	Organism/Species"	"Shank3	73	79	Gene/Protein"	"Shank3	130	136	Gene/Protein"	"metabotropic glutamate receptor 5	206	239	Gene/Protein"	"mGluR5	242	248	Gene/Protein"	"protein kinase B	338	354	Gene/Protein"	"PKB	357	360	Gene/Protein"	"Akt	363	366	Gene/Protein"	"mTOR	370	374	Gene/Protein"	"[{""token"": ""Shank3"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Organism/Species""}, {""token"": ""Shank3"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""metabotropic glutamate receptor 5"", ""start_span"": 206, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""mGluR5"", ""start_span"": 242, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase B"", ""start_span"": 338, ""end_span"": 354, ""type"": ""Gene/Protein""}, {""token"": ""PKB"", ""start_span"": 357, ""end_span"": 360, ""type"": ""Gene/Protein""}, {""token"": ""Akt"", ""start_span"": 363, ""end_span"": 366, ""type"": ""Gene/Protein""}, {""token"": ""mTOR"", ""start_span"": 370, ""end_span"": 374, ""type"": ""Gene/Protein""}]"
The primer sequences for real - time PCR are as follows: Mouse Shank3 forward 5 ′ TGGTTGGCAAGAGATCCAT 3 ′, reverse 5 ′ TTGGCCCCATAGAACAAAAG 3 ′ Mouse Gpr85 forward 5 ′ ATGCAGCCGACAACATTTTGC 3 ′, reverse 5 ′ CAGGTGGAGCCATTTTTGACA 3 ′ Mouse Clic6 forward 5 ′ CTCTGGGTTAGACTCTCAGGG 3 ′, reverse 5 ′ GGTGCCTCTGTGTCCATGTT 3 ′ Mouse Plk5 forward 5 ′ CGGCACCCTTGTCAGAGATG 3 ′, reverse 5 ′ TGGGGGAAAGGCAAACACAG 3 ′ Mouse Gapdh forward 5 ′ GGCATTGCTCTCAATGACAA 3 ′, reverse 5 ′ CCCTGTTGCTGTAGCCGTAT 3 ′	"Mouse	57	62	Organism/Species"	"Shank3	63	69	Gene/Protein"	"Mouse	144	149	Organism/Species"	"Gpr85	150	155	Gene/Protein"	"Mouse	233	238	Organism/Species"	"Clic6	239	244	Gene/Protein"	"Mouse	321	326	Organism/Species"	"Plk5	327	331	Gene/Protein"	"Mouse	407	412	Organism/Species"	"Gapdh	413	418	Gene/Protein"	"[{""token"": ""Mouse"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Organism/Species""}, {""token"": ""Shank3"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Mouse"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Organism/Species""}, {""token"": ""Gpr85"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Mouse"", ""start_span"": 233, ""end_span"": 238, ""type"": ""Organism/Species""}, {""token"": ""Clic6"", ""start_span"": 239, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""Mouse"", ""start_span"": 321, ""end_span"": 326, ""type"": ""Organism/Species""}, {""token"": ""Plk5"", ""start_span"": 327, ""end_span"": 331, ""type"": ""Gene/Protein""}, {""token"": ""Mouse"", ""start_span"": 407, ""end_span"": 412, ""type"": ""Organism/Species""}, {""token"": ""Gapdh"", ""start_span"": 413, ""end_span"": 418, ""type"": ""Gene/Protein""}]"
The red dotted circle indicates the components of wave regulatory complex ( WRC; WASF1; Abelson - interacting protein 1 ( ABI1 ), ABI2 and Cytoplasmic FMR1 - interacting protein 2 ( CYFIP2) and Ras - related C3 botulinum toxin substrate 1 ( RAC1 )). ( B) The diagrams show the atlas of mouse brain coronal sections for the striatum, and the coordinates of the exact areas where immunohistochemistry ( IHC) experiments were performed ( left panel ).	"wave	50	54	Gene/Protein"	"WASF1	81	86	Gene/Protein"	"Abelson - interacting protein 1	88	119	Gene/Protein"	"ABI1	122	126	Gene/Protein"	"ABI2	130	134	Gene/Protein"	"Cytoplasmic FMR1 - interacting protein 2	139	179	Gene/Protein"	"CYFIP2	182	188	Gene/Protein"	"Ras - related C3 botulinum toxin substrate 1	194	238	Gene/Protein"	"RAC1	241	245	Gene/Protein"	"mouse	286	291	Organism/Species"	"[{""token"": ""wave"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""WASF1"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""Abelson - interacting protein 1"", ""start_span"": 88, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""ABI1"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""ABI2"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""Cytoplasmic FMR1 - interacting protein 2"", ""start_span"": 139, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""CYFIP2"", ""start_span"": 182, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""Ras - related C3 botulinum toxin substrate 1"", ""start_span"": 194, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""RAC1"", ""start_span"": 241, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 286, ""end_span"": 291, ""type"": ""Organism/Species""}]"
We performed IP using the GFP - Trap beads to pull down EGFP - Shank3 and its interacting proteins from Shank3 TG mice, as described previously ( Han et al ., 2013b; Lee Y. et al ., 2017 ), and found that Shank3, Rhes, WAVE1 and Homer1b / c ( a known interactor of Shank3) proteins were pulled down together ( Figure 3D ).	"GFP	26	29	Gene/Protein"	"EGFP	56	60	Gene/Protein"	"Shank3	63	69	Gene/Protein"	"Shank3	104	110	Gene/Protein"	"mice	114	118	Organism/Species"	"Shank3	205	211	Gene/Protein"	"Rhes	213	217	Gene/Protein"	"WAVE1	219	224	Gene/Protein"	"Homer1b / c	229	240	Gene/Protein"	"Shank3	265	271	Gene/Protein"	"[{""token"": ""GFP"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""EGFP"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""Shank3"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""Rhes"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""WAVE1"", ""start_span"": 219, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""Homer1b / c"", ""start_span"": 229, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 265, ""end_span"": 271, ""type"": ""Gene/Protein""}]"
In support of this hypothesis, we found that 11 of the 94 proteins from Shank3 - mTORC1 interactome, including ACTN2, WAVE1, Abi and Rac1, were associated with actin filaments, and that levels of F - actin were increased in the dorsal striatum of Shank3 TG mice.	"Shank3	72	78	Gene/Protein"	"mTORC1	81	87	Gene/Protein"	"ACTN2	111	116	Gene/Protein"	"WAVE1	118	123	Gene/Protein"	"Abi	125	128	Gene/Protein"	"Rac1	133	137	Gene/Protein"	"actin	160	165	Gene/Protein"	"F - actin	196	205	Gene/Protein"	"Shank3	247	253	Gene/Protein"	"mice	257	261	Organism/Species"	"[{""token"": ""Shank3"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""ACTN2"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""WAVE1"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""Abi"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""Rac1"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""F - actin"", ""start_span"": 196, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 247, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 257, ""end_span"": 261, ""type"": ""Organism/Species""}]"
CDHR1, ARHGEF40 ( Rho guanine nucleotide exchange factor ( GEF) 40 ), CD9 ( CD9 molecule ), DST ( dystonin ), LRRN2 ( leucine rich repeat neuronal 2) and PCDH11X / Y ( protocadherin 11 Y - linked) support cell adhesion.	"CDHR1	0	5	Gene/Protein"	"ARHGEF40	7	15	Gene/Protein"	"CD9	70	73	Gene/Protein"	"CD9	76	79	Gene/Protein"	"DST	92	95	Gene/Protein"	"dystonin	98	106	Gene/Protein"	"LRRN2	110	115	Gene/Protein"	"leucine rich repeat neuronal 2	118	148	Gene/Protein"	"PCDH11X	154	161	Gene/Protein"	"protocadherin 11 Y - linked	168	195	Gene/Protein"	"[{""token"": ""CDHR1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""ARHGEF40"", ""start_span"": 7, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""CD9"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""CD9"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""DST"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""dystonin"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""LRRN2"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""leucine rich repeat neuronal 2"", ""start_span"": 118, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""PCDH11X"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""protocadherin 11 Y - linked"", ""start_span"": 168, ""end_span"": 195, ""type"": ""Gene/Protein""}]"
Memantine, AMPA, DNQX, MK - 801, nitrazepam, donepezil, and ondansetron were purchased from WAKO Pure Chemicals; ifenprodil, Ro25 - 6981, DL - AP7, felbamate, and loperamide were obtained from Sigma - Aldrich ( St. Louis, MO, USA ).	"Memantine	0	9	Chemical/Drug"	"MK - 801	23	31	Chemical/Drug"	"nitrazepam	33	43	Chemical/Drug"	"donepezil	45	54	Chemical/Drug"	"ondansetron	60	71	Chemical/Drug"	"ifenprodil	113	123	Chemical/Drug"	"Ro25 - 6981	125	136	Chemical/Drug"	"DL - AP7	138	146	Chemical/Drug"	"felbamate	148	157	Chemical/Drug"	"loperamide	163	173	Chemical/Drug"	"[{""token"": ""Memantine"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""MK - 801"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""nitrazepam"", ""start_span"": 33, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""donepezil"", ""start_span"": 45, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""ondansetron"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""ifenprodil"", ""start_span"": 113, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""Ro25 - 6981"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""DL - AP7"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""felbamate"", ""start_span"": 148, ""end_span"": 157, ""type"": ""Chemical/Drug""}, {""token"": ""loperamide"", ""start_span"": 163, ""end_span"": 173, ""type"": ""Chemical/Drug""}]"
Thus, the lncRNA uc. 134 - CUL4A - Hippo axis may offer a promising approach for the treatment of HCC ( Fig. 6e ). Fig. 6Expression levels of lncRNA uc. 134, LATS1, and pYAPS127 positively correlated in samples from patients with HCC. a The ISH and IHC staining of HCC paraffin - embedded samples showed that the expression levels of uc. 134, LATS1, and pYAPS127 were significantly downregulated in HCC ( 200 × magnification, n = 90 ). b – d A scatter diagram showed positive correlations among uc. 134 and LATS1 or pYAPS127. e A model for the regulatory mechanisms of uc. 134 in HCC	"CUL4A	27	32	Gene/Protein"	"Hippo	35	40	Gene/Protein"	"HCC	98	101	Disease/Disorder"	"LATS1	158	163	Gene/Protein"	"HCC	230	233	Disease/Disorder"	"HCC	265	268	Disease/Disorder"	"LATS1	343	348	Gene/Protein"	"HCC	399	402	Disease/Disorder"	"LATS1	507	512	Gene/Protein"	"HCC	580	583	Disease/Disorder"	"[{""token"": ""CUL4A"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""Hippo"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Disease/Disorder""}, {""token"": ""LATS1"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 230, ""end_span"": 233, ""type"": ""Disease/Disorder""}, {""token"": ""HCC"", ""start_span"": 265, ""end_span"": 268, ""type"": ""Disease/Disorder""}, {""token"": ""LATS1"", ""start_span"": 343, ""end_span"": 348, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 399, ""end_span"": 402, ""type"": ""Disease/Disorder""}, {""token"": ""LATS1"", ""start_span"": 507, ""end_span"": 512, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 580, ""end_span"": 583, ""type"": ""Disease/Disorder""}]"
In addition, when we co - transfected the HCC cells with plasmids expressing YAP and those expressing uc. 134, the decrease in the mRNA level of CYR61, c - Myc, diap1, and E2F1 was reversed by YAP, indicating that YAP is responsible for the uc. 134 - mediated gene regulation.	"HCC	42	45	Disease/Disorder"	"YAP	77	80	Gene/Protein"	"uc	102	104	Chemical/Drug"	"CYR61	145	150	Gene/Protein"	"c - Myc	152	159	Gene/Protein"	"diap1	161	166	Gene/Protein"	"E2F1	172	176	Gene/Protein"	"YAP	193	196	Gene/Protein"	"YAP	214	217	Gene/Protein"	"uc	241	243	Chemical/Drug"	"[{""token"": ""HCC"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Disease/Disorder""}, {""token"": ""YAP"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""uc"", ""start_span"": 102, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""CYR61"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""c - Myc"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""diap1"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""E2F1"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""YAP"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""YAP"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""uc"", ""start_span"": 241, ""end_span"": 243, ""type"": ""Chemical/Drug""}]"
NLR - A1 and NLR - A2, the fish orthologs of human NOD1 and NOD2 respectively, both possessed clear CARD domains ( one in NLR - A1 and two in NLR - A2) with high amino acid identity to the equivalent regions of human molecules.	"NLR - A1	0	8	Gene/Protein"	"NLR - A2	13	21	Gene/Protein"	"fish	27	31	Organism/Species"	"human	45	50	Organism/Species"	"NOD1	51	55	Gene/Protein"	"NOD2	60	64	Gene/Protein"	"NLR - A1	122	130	Gene/Protein"	"NLR - A2	142	150	Gene/Protein"	"amino acid	162	172	Chemical/Drug"	"human	211	216	Organism/Species"	"[{""token"": ""NLR - A1"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A2"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""fish"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""NOD1"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NOD2"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A1"", ""start_span"": 122, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A2"", ""start_span"": 142, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""amino acid"", ""start_span"": 162, ""end_span"": 172, ""type"": ""Chemical/Drug""}, {""token"": ""human"", ""start_span"": 211, ""end_span"": 216, ""type"": ""Organism/Species""}]"
Two other NLR - A subfamily members were also identified in zebrafish that were designated NLR - A4 and NLR - A5 with NLR - A4 resembling human NOD4 and NLR - A5 being highly conserved to human NOD5.	"NLR - A	10	17	Gene/Protein"	"zebrafish	60	69	Organism/Species"	"NLR - A4	91	99	Gene/Protein"	"NLR - A5	104	112	Gene/Protein"	"NLR - A4	118	126	Gene/Protein"	"human	138	143	Organism/Species"	"NOD4	144	148	Gene/Protein"	"NLR - A5	153	161	Gene/Protein"	"human	188	193	Organism/Species"	"NOD5	194	198	Gene/Protein"	"[{""token"": ""NLR - A"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""zebrafish"", ""start_span"": 60, ""end_span"": 69, ""type"": ""Organism/Species""}, {""token"": ""NLR - A4"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A5"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A4"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Organism/Species""}, {""token"": ""NOD4"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A5"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 188, ""end_span"": 193, ""type"": ""Organism/Species""}, {""token"": ""NOD5"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Gene/Protein""}]"
Flow cytometry analysis of CD14 + cells differentiated for 5 days with or without 50% conditioned media ( CM ), IFN - γ, IL - 4 and IL - 10 A mean fluorescence intensity ( MFI) of CD14 B CD16 C CD64 D CD163 E CD86 and F CD200R, normalized to MFI of unstained cells; n = 3, *** p < 0. 0005. ( PDF 1833 kb)	"CD14	27	31	Gene/Protein"	"IFN - γ	112	119	Gene/Protein"	"IL - 4	121	127	Gene/Protein"	"IL - 10	132	139	Gene/Protein"	"CD14	180	184	Gene/Protein"	"CD16	187	191	Gene/Protein"	"CD64	194	198	Gene/Protein"	"CD163	201	206	Gene/Protein"	"CD86	209	213	Gene/Protein"	"CD200R	220	226	Gene/Protein"	"[{""token"": ""CD14"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""IFN - \u03b3"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 121, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""CD64"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""CD163"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""CD200R"", ""start_span"": 220, ""end_span"": 226, ""type"": ""Gene/Protein""}]"
Representative flow cytometry dot plot of IL - 4 macrophages A human macrophages in the presence of IL - 4 with or without breast cancer cell line conditioned media ( CM ), detected with antibodies against CD14, CD16, CD163, CD200R and CD86 B mean fluorescence intensity ( MFI) of the analyzed surface - markers. ( PDF 2715 kb)	"IL - 4	42	48	Gene/Protein"	"human	63	68	Organism/Species"	"IL - 4	100	106	Gene/Protein"	"breast cancer	123	136	Disease/Disorder"	"antibodies	187	197	Gene/Protein"	"CD14	206	210	Gene/Protein"	"CD16	212	216	Gene/Protein"	"CD163	218	223	Gene/Protein"	"CD200R	225	231	Gene/Protein"	"CD86	236	240	Gene/Protein"	"[{""token"": ""IL - 4"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Organism/Species""}, {""token"": ""IL - 4"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 123, ""end_span"": 136, ""type"": ""Disease/Disorder""}, {""token"": ""antibodies"", ""start_span"": 187, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""CD163"", ""start_span"": 218, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""CD200R"", ""start_span"": 225, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 236, ""end_span"": 240, ""type"": ""Gene/Protein""}]"
The evidence of vitamin D malabsorption ( Osteomalacia, rickets, hypocalcaemia, or reduced circulating concentration of 25 ( OH) D) persists despite routine vitamin D supplementation in cystic fibrosis [ 14 ], Crohn ’ s disease [ 15 ], Intestinal resection [ 16 – 19 ], ulcerative colitis, liver disease [ 20 – 22] and other malabsorption syndrome [ 23 ].	"vitamin D	16	25	Chemical/Drug"	"Osteomalacia	42	54	Disease/Disorder"	"rickets	56	63	Disease/Disorder"	"hypocalcaemia	65	78	Disease/Disorder"	"vitamin D	157	166	Chemical/Drug"	"cystic fibrosis	186	201	Disease/Disorder"	"Crohn ’ s disease	210	227	Disease/Disorder"	"ulcerative colitis	270	288	Disease/Disorder"	"liver disease	290	303	Disease/Disorder"	"malabsorption syndrome	325	347	Disease/Disorder"	"[{""token"": ""vitamin D"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""Osteomalacia"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Disease/Disorder""}, {""token"": ""rickets"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Disease/Disorder""}, {""token"": ""hypocalcaemia"", ""start_span"": 65, ""end_span"": 78, ""type"": ""Disease/Disorder""}, {""token"": ""vitamin D"", ""start_span"": 157, ""end_span"": 166, ""type"": ""Chemical/Drug""}, {""token"": ""cystic fibrosis"", ""start_span"": 186, ""end_span"": 201, ""type"": ""Disease/Disorder""}, {""token"": ""Crohn \u2019 s disease"", ""start_span"": 210, ""end_span"": 227, ""type"": ""Disease/Disorder""}, {""token"": ""ulcerative colitis"", ""start_span"": 270, ""end_span"": 288, ""type"": ""Disease/Disorder""}, {""token"": ""liver disease"", ""start_span"": 290, ""end_span"": 303, ""type"": ""Disease/Disorder""}, {""token"": ""malabsorption syndrome"", ""start_span"": 325, ""end_span"": 347, ""type"": ""Disease/Disorder""}]"
Most of the sequences retrieved were closely related to common fish coccidia of Eimeria, Goussia and Calyptospora. However, some lineages from the shark Scyliorhinus canicula were placed as sister taxa to the Isospora, Caryospora and Schellakia group.	"fish	63	67	Organism/Species"	"coccidia	68	76	Organism/Species"	"Eimeria	80	87	Organism/Species"	"Goussia	89	96	Organism/Species"	"Calyptospora	101	113	Organism/Species"	"shark	147	152	Organism/Species"	"Scyliorhinus canicula	153	174	Organism/Species"	"Isospora	209	217	Organism/Species"	"Caryospora	219	229	Organism/Species"	"Schellakia	234	244	Organism/Species"	"[{""token"": ""fish"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""coccidia"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Organism/Species""}, {""token"": ""Eimeria"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Organism/Species""}, {""token"": ""Goussia"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Organism/Species""}, {""token"": ""Calyptospora"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Organism/Species""}, {""token"": ""shark"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Organism/Species""}, {""token"": ""Scyliorhinus canicula"", ""start_span"": 153, ""end_span"": 174, ""type"": ""Organism/Species""}, {""token"": ""Isospora"", ""start_span"": 209, ""end_span"": 217, ""type"": ""Organism/Species""}, {""token"": ""Caryospora"", ""start_span"": 219, ""end_span"": 229, ""type"": ""Organism/Species""}, {""token"": ""Schellakia"", ""start_span"": 234, ""end_span"": 244, ""type"": ""Organism/Species""}]"
The genetic diversity of coccidia infecting fish has been largely neglected; for marine fish there is just a description of an Eimeria sp. from farmed Asian sea bass [ 10 ], later identified as Goussia kuehae [ 11 ], the genetic characterization of G. clupearum from Atlantic herring [ 12 ], and a description of Apicomplexa spp. from Caribbean reef fish ( Stegastes spp. and Ophioblennius macclurei) [ 13 ].	"coccidia	25	33	Organism/Species"	"fish	44	48	Organism/Species"	"fish	88	92	Organism/Species"	"Eimeria sp	127	137	Organism/Species"	"Goussia kuehae	194	208	Organism/Species"	"Atlantic herring	267	283	Organism/Species"	"Apicomplexa spp	313	328	Organism/Species"	"reef fish	345	354	Organism/Species"	"Stegastes spp	357	370	Organism/Species"	"Ophioblennius macclurei	376	399	Organism/Species"	"[{""token"": ""coccidia"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Organism/Species""}, {""token"": ""Eimeria sp"", ""start_span"": 127, ""end_span"": 137, ""type"": ""Organism/Species""}, {""token"": ""Goussia kuehae"", ""start_span"": 194, ""end_span"": 208, ""type"": ""Organism/Species""}, {""token"": ""Atlantic herring"", ""start_span"": 267, ""end_span"": 283, ""type"": ""Organism/Species""}, {""token"": ""Apicomplexa spp"", ""start_span"": 313, ""end_span"": 328, ""type"": ""Organism/Species""}, {""token"": ""reef fish"", ""start_span"": 345, ""end_span"": 354, ""type"": ""Organism/Species""}, {""token"": ""Stegastes spp"", ""start_span"": 357, ""end_span"": 370, ""type"": ""Organism/Species""}, {""token"": ""Ophioblennius macclurei"", ""start_span"": 376, ""end_span"": 399, ""type"": ""Organism/Species""}]"
Some of the Apicomplexa sequenced from S. canicula were recovered in the present phylogenetic analysis as sister to coccidia from the Eimeriidae ( Isospora, Caryospora) and Schellakiidae ( Schellakia) that infect amphibians and reptiles, including marine turtles ( Fig. 3 ).	"Apicomplexa	12	23	Organism/Species"	"coccidia	116	124	Organism/Species"	"Eimeriidae	134	144	Organism/Species"	"Isospora	147	155	Organism/Species"	"Caryospora	157	167	Organism/Species"	"Schellakiidae	173	186	Organism/Species"	"Schellakia	189	199	Organism/Species"	"amphibians	213	223	Organism/Species"	"reptiles	228	236	Organism/Species"	"turtles	255	262	Organism/Species"	"[{""token"": ""Apicomplexa"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Organism/Species""}, {""token"": ""coccidia"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""Eimeriidae"", ""start_span"": 134, ""end_span"": 144, ""type"": ""Organism/Species""}, {""token"": ""Isospora"", ""start_span"": 147, ""end_span"": 155, ""type"": ""Organism/Species""}, {""token"": ""Caryospora"", ""start_span"": 157, ""end_span"": 167, ""type"": ""Organism/Species""}, {""token"": ""Schellakiidae"", ""start_span"": 173, ""end_span"": 186, ""type"": ""Organism/Species""}, {""token"": ""Schellakia"", ""start_span"": 189, ""end_span"": 199, ""type"": ""Organism/Species""}, {""token"": ""amphibians"", ""start_span"": 213, ""end_span"": 223, ""type"": ""Organism/Species""}, {""token"": ""reptiles"", ""start_span"": 228, ""end_span"": 236, ""type"": ""Organism/Species""}, {""token"": ""turtles"", ""start_span"": 255, ""end_span"": 262, ""type"": ""Organism/Species""}]"
( F) Repressive potential of REV - ERBα in Hepa - 1c1c7 cells on the Bmal1 :: luc, the Fgf21 :: luc and the Hnf6 site mutated Fgf21 :: luc ( mut Fgf21 :: luc) reporters ( n = 3 ).	"REV - ERBα	29	39	Gene/Protein"	"Bmal1	69	74	Gene/Protein"	"luc	78	81	Gene/Protein"	"Fgf21	87	92	Gene/Protein"	"luc	96	99	Gene/Protein"	"Hnf6	108	112	Gene/Protein"	"Fgf21	126	131	Gene/Protein"	"luc	135	138	Gene/Protein"	"Fgf21	145	150	Gene/Protein"	"luc	154	157	Gene/Protein"	"[{""token"": ""REV - ERB\u03b1"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""Bmal1"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""Hnf6"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}]"
Expression plasmids pSCT1 - PPARα, pSCT1 - RXRα, pSCT1 - PER2, pSCT1 - LacZ ( β - galactosidase ), pSCT1 - REV - ERBα, pSCT1 - RORα and Bmal1 luciferase construct ( with PPAR regulatory site) are described ( Schmutz et al ., 2010 ).	"PPARα	28	33	Gene/Protein"	"RXRα	43	47	Gene/Protein"	"PER2	57	61	Gene/Protein"	"LacZ	71	75	Gene/Protein"	"β - galactosidase	78	95	Gene/Protein"	"REV - ERBα	107	117	Gene/Protein"	"RORα	127	131	Gene/Protein"	"Bmal1	136	141	Gene/Protein"	"luciferase	142	152	Gene/Protein"	"PPAR	170	174	Gene/Protein"	"[{""token"": ""PPAR\u03b1"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""RXR\u03b1"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""PER2"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""LacZ"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - galactosidase"", ""start_span"": 78, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""REV - ERB\u03b1"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""ROR\u03b1"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""Bmal1"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 142, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""PPAR"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene/Protein""}]"
We assembled a matrix of gene family sizes for: Canis familiaris ( dog ), Rattus norvegicus ( rat ), Mus musculus ( mouse ), Pan troglodytes ( chimp ), and Homo sapiens ( human ), for analysis of mammalian gene family evolution.	"Canis familiaris	48	64	Organism/Species"	"dog	67	70	Organism/Species"	"Rattus norvegicus	74	91	Organism/Species"	"rat	94	97	Organism/Species"	"Mus musculus	101	113	Organism/Species"	"mouse	116	121	Organism/Species"	"Pan troglodytes	125	140	Organism/Species"	"chimp	143	148	Organism/Species"	"Homo sapiens	156	168	Organism/Species"	"human	171	176	Organism/Species"	"[{""token"": ""Canis familiaris"", ""start_span"": 48, ""end_span"": 64, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Organism/Species""}, {""token"": ""Rattus norvegicus"", ""start_span"": 74, ""end_span"": 91, ""type"": ""Organism/Species""}, {""token"": ""rat"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Organism/Species""}, {""token"": ""Mus musculus"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Organism/Species""}, {""token"": ""Pan troglodytes"", ""start_span"": 125, ""end_span"": 140, ""type"": ""Organism/Species""}, {""token"": ""chimp"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Organism/Species""}, {""token"": ""Homo sapiens"", ""start_span"": 156, ""end_span"": 168, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Organism/Species""}]"
The NF - κB family consists of the following five transcription factors: RelA ( p65 ), RelB, c - Rel, p100 / p52, and p105 / p50; these factors can homo or heterodimerize to allow DNA binding and activate transcription.	"NF - κB	4	11	Gene/Protein"	"transcription factors	50	71	Gene/Protein"	"RelA	73	77	Gene/Protein"	"p65	80	83	Gene/Protein"	"RelB	87	91	Gene/Protein"	"c - Rel	93	100	Gene/Protein"	"p100	102	106	Gene/Protein"	"p52	109	112	Gene/Protein"	"p105	118	122	Gene/Protein"	"p50	125	128	Gene/Protein"	"[{""token"": ""NF - \u03baB"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 50, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""p100"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene/Protein""}]"
Baldwin AS in 2010 using Her2 +/ ER - breast cancer cells, showed that HER2 activates NF - kappa B via IKKα and hypothesized that NIK might be activating IKKα since NIK has been associated to the ErbB2 family member EGFR37.	"Her2	25	29	Gene/Protein"	"breast cancer	38	51	Disease/Disorder"	"HER2	71	75	Gene/Protein"	"NF - kappa B	86	98	Gene/Protein"	"IKKα	103	107	Gene/Protein"	"NIK	130	133	Gene/Protein"	"IKKα	154	158	Gene/Protein"	"NIK	165	168	Gene/Protein"	"ErbB2	196	201	Gene/Protein"	"EGFR37	216	222	Gene/Protein"	"[{""token"": ""Her2"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Disease/Disorder""}, {""token"": ""HER2"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IKK\u03b1"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""IKK\u03b1"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""ErbB2"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""EGFR37"", ""start_span"": 216, ""end_span"": 222, ""type"": ""Gene/Protein""}]"
We detected NF - κB, Notch, P53, STAT3, and Wnt / β - catenin signal pathway luciferase reporter activity by ectopic expression of MARCH7 in ovarian cancer A2780 cells infected with LV5 - MARCH7.	"NF - κB	12	19	Gene/Protein"	"Notch	21	26	Gene/Protein"	"P53	28	31	Gene/Protein"	"STAT3	33	38	Gene/Protein"	"Wnt	44	47	Gene/Protein"	"β - catenin	50	61	Gene/Protein"	"luciferase	77	87	Gene/Protein"	"MARCH7	131	137	Gene/Protein"	"ovarian cancer	141	155	Disease/Disorder"	"MARCH7	188	194	Gene/Protein"	"[{""token"": ""NF - \u03baB"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""Notch"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""P53"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""MARCH7"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""ovarian cancer"", ""start_span"": 141, ""end_span"": 155, ""type"": ""Disease/Disorder""}, {""token"": ""MARCH7"", ""start_span"": 188, ""end_span"": 194, ""type"": ""Gene/Protein""}]"
In neurons, β1 increases neurite length via fyn kinase. 15 CAM - mediated activation of fyn kinase is proposed to initiate the fyn - focal adhesion kinase ( FAK) pathway, activating extracellular signal - regulated kinase 1 / 2, leading to neurite outgrowth. 38 Fyn is upregulated in a number of cancers, where it contributes to an invasive phenotype. 39 We found that fyn, like β1, was expressed in MCF - 10A cells and BCa cell lines ( Fig. 1g and 1h, Supporting Information Fig.	"fyn kinase	44	54	Gene/Protein"	"fyn kinase	88	98	Gene/Protein"	"fyn	127	130	Gene/Protein"	"focal adhesion kinase	133	154	Gene/Protein"	"FAK	157	160	Gene/Protein"	"extracellular signal - regulated kinase 1	182	223	Gene/Protein"	"Fyn	262	265	Gene/Protein"	"cancers	296	303	Disease/Disorder"	"fyn	369	372	Gene/Protein"	"BCa	420	423	Disease/Disorder"	"[{""token"": ""fyn kinase"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""fyn kinase"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""fyn"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""focal adhesion kinase"", ""start_span"": 133, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""FAK"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""extracellular signal - regulated kinase 1"", ""start_span"": 182, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""Fyn"", ""start_span"": 262, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""cancers"", ""start_span"": 296, ""end_span"": 303, ""type"": ""Disease/Disorder""}, {""token"": ""fyn"", ""start_span"": 369, ""end_span"": 372, ""type"": ""Gene/Protein""}, {""token"": ""BCa"", ""start_span"": 420, ""end_span"": 423, ""type"": ""Disease/Disorder""}]"
When the Ran – exportin nuclear export pathway was blocked with leptomycin B ( LMB ), a potent inhibitor of exportin / Crm1 [ 28 ], Spo5 – GFP remained in the cytoplasm ( Figure 2D ), demonstrating that exportin / Crm1 is dispensable for the export of Spo5.	"Ran	9	12	Gene/Protein"	"exportin	15	23	Gene/Protein"	"leptomycin B	64	76	Chemical/Drug"	"exportin	108	116	Gene/Protein"	"Crm1	119	123	Gene/Protein"	"Spo5	132	136	Gene/Protein"	"GFP	139	142	Gene/Protein"	"exportin	203	211	Gene/Protein"	"Crm1	214	218	Gene/Protein"	"Spo5	252	256	Gene/Protein"	"[{""token"": ""Ran"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""exportin"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""leptomycin B"", ""start_span"": 64, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""exportin"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Crm1"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""Spo5"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""exportin"", ""start_span"": 203, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""Crm1"", ""start_span"": 214, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""Spo5"", ""start_span"": 252, ""end_span"": 256, ""type"": ""Gene/Protein""}]"
h 90 spo5 ( S365P )- GFP - kan cut11 - 4mRFP - hph CFP - atb2 - nat ade6 - M216 leu1 ura4	"spo5	5	9	Gene/Protein"	"GFP	21	24	Gene/Protein"	"cut11	31	36	Gene/Protein"	"hph	47	50	Gene/Protein"	"CFP	51	54	Gene/Protein"	"atb2	57	61	Gene/Protein"	"nat	64	67	Gene/Protein"	"ade6	68	72	Gene/Protein"	"leu1	80	84	Gene/Protein"	"ura4	85	89	Gene/Protein"	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""cut11"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CFP"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""atb2"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""nat"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}]"
h 90 spo5 - GFP - kan cut11 - 4mRFP - hph CFP - atb2 - nat ade6 - M216 leu1 ura4	"spo5	5	9	Gene/Protein"	"GFP	12	15	Gene/Protein"	"cut11	22	27	Gene/Protein"	"hph	38	41	Gene/Protein"	"CFP	42	45	Gene/Protein"	"atb2	48	52	Gene/Protein"	"nat	55	58	Gene/Protein"	"ade6	59	63	Gene/Protein"	"leu1	71	75	Gene/Protein"	"ura4	76	80	Gene/Protein"	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""cut11"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""CFP"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""atb2"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""nat"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}]"
h 90 spo5 ( 1 – 525 )- GFP - kan cut11 - 4mRFP - hph CFP - atb2 - nat ade6 - M216 leu1 ura4	"spo5	5	9	Gene/Protein"	"GFP	23	26	Gene/Protein"	"cut11	33	38	Gene/Protein"	"hph	49	52	Gene/Protein"	"CFP	53	56	Gene/Protein"	"atb2	59	63	Gene/Protein"	"nat	66	69	Gene/Protein"	"ade6	70	74	Gene/Protein"	"leu1	82	86	Gene/Protein"	"ura4	87	91	Gene/Protein"	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""cut11"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""CFP"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""atb2"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""nat"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}]"
h 90 spo5 ( F341L )- GFP - kan cut11 - 4mRFP - hph CFP - atb2 - nat ade6 - M216 leu1 ura4	"spo5	5	9	Gene/Protein"	"GFP	21	24	Gene/Protein"	"cut11	31	36	Gene/Protein"	"hph	47	50	Gene/Protein"	"CFP	51	54	Gene/Protein"	"atb2	57	61	Gene/Protein"	"nat	64	67	Gene/Protein"	"ade6	68	72	Gene/Protein"	"leu1	80	84	Gene/Protein"	"ura4	85	89	Gene/Protein"	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""cut11"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CFP"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""atb2"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""nat"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}]"
h 90 spo5 ( 1 – 296 )- GFP - kan cut11 - 4mRFP - hph CFP - atb2 - nat ade6 - M216 leu1 ura4	"spo5	5	9	Gene/Protein"	"GFP	23	26	Gene/Protein"	"cut11	33	38	Gene/Protein"	"hph	49	52	Gene/Protein"	"CFP	53	56	Gene/Protein"	"atb2	59	63	Gene/Protein"	"nat	66	69	Gene/Protein"	"ade6	70	74	Gene/Protein"	"leu1	82	86	Gene/Protein"	"ura4	87	91	Gene/Protein"	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""cut11"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""CFP"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""atb2"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""nat"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}]"
h 90 spo5 ( 1 – 366 )- GFP - kan cut11 - 4mRFP - hph CFP - atb2 - nat ade6 - M216 leu1 ura4	"spo5	5	9	Gene/Protein"	"GFP	23	26	Gene/Protein"	"cut11	33	38	Gene/Protein"	"hph	49	52	Gene/Protein"	"CFP	53	56	Gene/Protein"	"atb2	59	63	Gene/Protein"	"nat	66	69	Gene/Protein"	"ade6	70	74	Gene/Protein"	"leu1	82	86	Gene/Protein"	"ura4	87	91	Gene/Protein"	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""cut11"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""CFP"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""atb2"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""nat"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}]"
h 90 spo5 ( 1 – 456 )- GFP - kan cut11 - 4mRFP - hph CFP - atb2 - nat ade6 - M216 leu1 ura4	"spo5	5	9	Gene/Protein"	"GFP	23	26	Gene/Protein"	"cut11	33	38	Gene/Protein"	"hph	49	52	Gene/Protein"	"CFP	53	56	Gene/Protein"	"atb2	59	63	Gene/Protein"	"nat	66	69	Gene/Protein"	"ade6	70	74	Gene/Protein"	"leu1	82	86	Gene/Protein"	"ura4	87	91	Gene/Protein"	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""cut11"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""CFP"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""atb2"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""nat"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}]"
h + / h - spo5 - GFP - kan / spo5 - GFP - kan ade6 - M216 / ade6 - M210 leu1 / leu1 ura4 / ura4	"spo5	10	14	Gene/Protein"	"GFP	17	20	Gene/Protein"	"spo5	29	33	Gene/Protein"	"GFP	36	39	Gene/Protein"	"ade6	46	50	Gene/Protein"	"ade6	60	64	Gene/Protein"	"leu1	72	76	Gene/Protein"	"leu1	79	83	Gene/Protein"	"ura4	84	88	Gene/Protein"	"ura4	91	95	Gene/Protein"	"[{""token"": ""spo5"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""spo5"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}]"
h + / h - spo5 :: ura4 + / spo5 :: ura4 + ade6 - M216 / ade6 - M210 leu1 / leu1 ura4 / ura4	"spo5	10	14	Gene/Protein"	"ura4	18	22	Gene/Protein"	"spo5	27	31	Gene/Protein"	"ura4	35	39	Gene/Protein"	"ade6	42	46	Gene/Protein"	"ade6	56	60	Gene/Protein"	"leu1	68	72	Gene/Protein"	"leu1	75	79	Gene/Protein"	"ura4	80	84	Gene/Protein"	"ura4	87	91	Gene/Protein"	"[{""token"": ""spo5"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""spo5"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}]"
Compared to those in healthy controls, the numbers of CD38 + CD19 +, CD86 + CD19 +, CD38 + CD86 + CD19 +, and CD95 + CD19 + B cells per microliter of blood were significantly higher in HSPN patients.	"CD38	54	58	Gene/Protein"	"CD19	61	65	Gene/Protein"	"CD86	69	73	Gene/Protein"	"CD19	76	80	Gene/Protein"	"CD38	84	88	Gene/Protein"	"CD86	91	95	Gene/Protein"	"CD19	98	102	Gene/Protein"	"CD95	110	114	Gene/Protein"	"CD19	117	121	Gene/Protein"	"HSPN	185	189	Disease/Disorder"	"[{""token"": ""CD38"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""CD38"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""CD95"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""HSPN"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Disease/Disorder""}]"
Subsequently, we analyzed the numbers of CD5 + CD19 +, CD1d + CD5 + CD19 +, and IL - 10 + CD1d + CD5 + CD19 + B cells among CD19 + B cells, and at least 30, 000 events per sample were analyzed.	"CD5	41	44	Gene/Protein"	"CD19	47	51	Gene/Protein"	"CD1d	55	59	Gene/Protein"	"CD5	62	65	Gene/Protein"	"CD19	68	72	Gene/Protein"	"IL - 10	80	87	Gene/Protein"	"CD1d	90	94	Gene/Protein"	"CD5	97	100	Gene/Protein"	"CD19	103	107	Gene/Protein"	"CD19	124	128	Gene/Protein"	"[{""token"": ""CD5"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene/Protein""}]"
In this case, we found that eGFR was positively correlated with the numbers of IL - 10 + CD19 + ( Fig 3B, P = 0. 0003, R = 0. 7404 ), CD1d + CD5 + CD19 + ( Fig 3C, P = 0. 0397, R = 0. 4754 ), and IL - 10 + CD1d + CD5 + CD19 + B cells ( Fig 3D, P = 0. 0477, R = 0. 4596) per microliter of blood and the IL - 10 serum concentration ( Fig 3E, P = 0. 0086, R = 0. 5842 ).	"IL - 10	79	86	Gene/Protein"	"CD19	89	93	Gene/Protein"	"CD1d	134	138	Gene/Protein"	"CD5	141	144	Gene/Protein"	"CD19	147	151	Gene/Protein"	"IL - 10	196	203	Gene/Protein"	"CD1d	206	210	Gene/Protein"	"CD5	213	216	Gene/Protein"	"CD19	219	223	Gene/Protein"	"IL - 10	302	309	Gene/Protein"	"[{""token"": ""IL - 10"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 213, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 219, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 302, ""end_span"": 309, ""type"": ""Gene/Protein""}]"
However, the 24 - h proteinuria was negatively correlated with the numbers of IL - 10 + CD19 + ( Fig 3G, P = 0. 0077, R = – 0. 5912 ), CD1d + CD5 + CD19 + ( Fig 3H, P = 0. 0154, R = – 0. 5467 ), and IL - 10 + CD1d + CD5 + CD19 + B cells ( Fig 3I, P = 0. 0021, R = – 0. 6591) per microliter of blood and serum concentration of IL - 10 ( Fig 3J, P = 0. 0232, R = – 0. 5175 ).	"IL - 10	78	85	Gene/Protein"	"CD19	88	92	Gene/Protein"	"CD1d	135	139	Gene/Protein"	"CD5	142	145	Gene/Protein"	"CD19	148	152	Gene/Protein"	"IL - 10	199	206	Gene/Protein"	"CD1d	209	213	Gene/Protein"	"CD5	216	219	Gene/Protein"	"CD19	222	226	Gene/Protein"	"IL - 10	326	333	Gene/Protein"	"[{""token"": ""IL - 10"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 199, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 222, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 326, ""end_span"": 333, ""type"": ""Gene/Protein""}]"
( B) The eGFR was positively correlated with the numbers of IL - 10 + CD19 + B cells, ( C) CD1d + CD5 + CD19 + B cells ( D ), and IL - 10 + CD1d + CD5 + CD19 + B cells ( E) as well as the serum concentration of IL - 10.	"IL - 10	60	67	Gene/Protein"	"CD19	70	74	Gene/Protein"	"CD1d	91	95	Gene/Protein"	"CD5	98	101	Gene/Protein"	"CD19	104	108	Gene/Protein"	"IL - 10	130	137	Gene/Protein"	"CD1d	140	144	Gene/Protein"	"CD5	147	150	Gene/Protein"	"CD19	153	157	Gene/Protein"	"IL - 10	211	218	Gene/Protein"	"[{""token"": ""IL - 10"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Gene/Protein""}]"
( G) The 24 - h urinary protein concentration was negatively correlated with the numbers of IL - 10 + CD19 + B cells, ( H) CD1d + CD5 + CD19 + B cells, and ( I) IL - 10 + CD1d + CD5 + CD19 + B cells as well as the ( J) serum concentration of IL - 10.	"IL - 10	92	99	Gene/Protein"	"CD19	102	106	Gene/Protein"	"CD1d	123	127	Gene/Protein"	"CD5	130	133	Gene/Protein"	"CD19	136	140	Gene/Protein"	"IL - 10	161	168	Gene/Protein"	"CD1d	171	175	Gene/Protein"	"CD5	178	181	Gene/Protein"	"CD19	184	188	Gene/Protein"	"IL - 10	242	249	Gene/Protein"	"[{""token"": ""IL - 10"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 184, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 242, ""end_span"": 249, ""type"": ""Gene/Protein""}]"
We found that compared to those in HCs, the numbers of CD38 + CD19 +, CD86 + CD19 +, CD38 + CD86 + CD19 +, and CD95 + CD19 + B cells were significantly higher in patients with HSPN.	"CD38	55	59	Gene/Protein"	"CD19	62	66	Gene/Protein"	"CD86	70	74	Gene/Protein"	"CD19	77	81	Gene/Protein"	"CD38	85	89	Gene/Protein"	"CD86	92	96	Gene/Protein"	"CD19	99	103	Gene/Protein"	"CD95	111	115	Gene/Protein"	"CD19	118	122	Gene/Protein"	"HSPN	176	180	Disease/Disorder"	"[{""token"": ""CD38"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""CD38"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""CD95"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""HSPN"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Disease/Disorder""}]"
Furthermore, 24 - h proteinuria was negatively correlated with the serum IL - 10 concentration and the numbers of IL - 10 + CD19 +, CD1d + CD5 + CD19 +, and IL - 10 + CD1d + CD5 + CD19 + B cells.	"IL - 10	73	80	Gene/Protein"	"IL - 10	114	121	Gene/Protein"	"CD19	124	128	Gene/Protein"	"CD1d	132	136	Gene/Protein"	"CD5	139	142	Gene/Protein"	"CD19	145	149	Gene/Protein"	"IL - 10	157	164	Gene/Protein"	"CD1d	167	171	Gene/Protein"	"CD5	174	177	Gene/Protein"	"CD19	180	184	Gene/Protein"	"[{""token"": ""IL - 10"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}]"
In addition, the eGFR was positively correlated with the serum IL - 10 concentration and the numbers of IL - 10 + CD19 +, CD1d + CD5 + CD19 +, and IL - 10 + CD1d + CD5 + CD19 + B cells.	"IL - 10	63	70	Gene/Protein"	"IL - 10	104	111	Gene/Protein"	"CD19	114	118	Gene/Protein"	"CD1d	122	126	Gene/Protein"	"CD5	129	132	Gene/Protein"	"CD19	135	139	Gene/Protein"	"IL - 10	147	154	Gene/Protein"	"CD1d	157	161	Gene/Protein"	"CD5	164	167	Gene/Protein"	"CD19	170	174	Gene/Protein"	"[{""token"": ""IL - 10"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene/Protein""}]"
Interestingly, serum IL - 10 levels and the numbers of IL - 10 + CD19 +, CD1d + CD5 + CD19 +, and IL - 10 + CD1d + CD5 + CD19 + B cells were significantly greater in patients following treatment.	"IL - 10	21	28	Gene/Protein"	"IL - 10	55	62	Gene/Protein"	"CD19	65	69	Gene/Protein"	"CD1d	73	77	Gene/Protein"	"CD5	80	83	Gene/Protein"	"CD19	86	90	Gene/Protein"	"IL - 10	98	105	Gene/Protein"	"CD1d	108	112	Gene/Protein"	"CD5	115	118	Gene/Protein"	"CD19	121	125	Gene/Protein"	"[{""token"": ""IL - 10"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}]"
For detailed information on all inclusion / exclusion criteria, see the study protocol of the intervention study [ 21 ]. Table 1 Participants ’ characteristics Total ( n = 149) Socio - demographic factors (%) Female74. 5Living alone ( n = 148) 58. 1SES * ( n = 123) Low39. 0 Middle51. 2 High9. 8 Anthropometric data ( mean ± SD) Age [ years] 79. 5 ± 5. 2BMI [ kg / m2] 30. 3 ± 5. 5 Functional tests ( mean ± SD) Timed up - and go [ s] 12. 8 ± 4. 5Grip strength ( dominant hand) [ kg] 24. 2 ± 8. 3Chair - rise [ s] 20. 0 ± 10. 2Tandem stand [ s] 8. 7 ± 2. 4 Chronic diseases (%) Hypertension89. 3Type 2 diabetes34. 2Chronic ischemic heart disease28. 9Heart failure34. 9Peripheral arterial disease13. 4COPD21. 5Chronic kidney disease19. 5Spinal osteochondrosis67. 8Osteoarthritis of the hip47. 7Osteoarthritis of the knee60. 4Osteoporosis20. 1Number of specified diseases 14. 7 2 - 330. 2 4 - 538. 9 ≥ 626. 2 Mobility limitation and falls (%) No walking aid49. 7Cane28. 2Rollator22. 1Falls in the last 12 months ( n = 147) 071. 4 1 - 223. 8 ≥ 34. 8 SD standard deviation; COPD chronic obstructive pulmonary disease ;* Socioeconomic status determined by education, job and income.	"Chronic diseases	557	573	Disease/Disorder"	"Hypertension89	578	592	Disease/Disorder"	"2 diabetes34	600	612	Disease/Disorder"	"ischemic heart disease28	623	647	Disease/Disorder"	"failure34	656	665	Disease/Disorder"	"arterial disease13	679	697	Disease/Disorder"	"kidney disease19	717	733	Disease/Disorder"	"osteochondrosis67	743	760	Disease/Disorder"	"COPD	1070	1074	Disease/Disorder"	"chronic obstructive pulmonary disease	1075	1112	Disease/Disorder"	"[{""token"": ""Chronic diseases"", ""start_span"": 557, ""end_span"": 573, ""type"": ""Disease/Disorder""}, {""token"": ""Hypertension89"", ""start_span"": 578, ""end_span"": 592, ""type"": ""Disease/Disorder""}, {""token"": ""2 diabetes34"", ""start_span"": 600, ""end_span"": 612, ""type"": ""Disease/Disorder""}, {""token"": ""ischemic heart disease28"", ""start_span"": 623, ""end_span"": 647, ""type"": ""Disease/Disorder""}, {""token"": ""failure34"", ""start_span"": 656, ""end_span"": 665, ""type"": ""Disease/Disorder""}, {""token"": ""arterial disease13"", ""start_span"": 679, ""end_span"": 697, ""type"": ""Disease/Disorder""}, {""token"": ""kidney disease19"", ""start_span"": 717, ""end_span"": 733, ""type"": ""Disease/Disorder""}, {""token"": ""osteochondrosis67"", ""start_span"": 743, ""end_span"": 760, ""type"": ""Disease/Disorder""}, {""token"": ""COPD"", ""start_span"": 1070, ""end_span"": 1074, ""type"": ""Disease/Disorder""}, {""token"": ""chronic obstructive pulmonary disease"", ""start_span"": 1075, ""end_span"": 1112, ""type"": ""Disease/Disorder""}]"
SOCS, Suppressor of Cytokine Signalling; SHP, SH2 - containing protein tyrosine Phosphatase; PD - L1, Programmed Death Ligand 1; TGF, Transforming Growth Factor; GAPDH, Glyceraldehyde 3 - Phosphatase Dehydrogenase	"SOCS	0	4	Gene/Protein"	"Suppressor of Cytokine Signalling	6	39	Gene/Protein"	"SHP	41	44	Gene/Protein"	"SH2 - containing protein tyrosine Phosphatase	46	91	Gene/Protein"	"PD - L1	93	100	Gene/Protein"	"Programmed Death Ligand 1	102	127	Gene/Protein"	"TGF	129	132	Gene/Protein"	"Transforming Growth Factor	134	160	Gene/Protein"	"GAPDH	162	167	Gene/Protein"	"Glyceraldehyde 3 - Phosphatase Dehydrogenase	169	213	Gene/Protein"	"[{""token"": ""SOCS"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""Suppressor of Cytokine Signalling"", ""start_span"": 6, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""SHP"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""SH2 - containing protein tyrosine Phosphatase"", ""start_span"": 46, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""PD - L1"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Programmed Death Ligand 1"", ""start_span"": 102, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""TGF"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Transforming Growth Factor"", ""start_span"": 134, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""GAPDH"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""Glyceraldehyde 3 - Phosphatase Dehydrogenase"", ""start_span"": 169, ""end_span"": 213, ""type"": ""Gene/Protein""}]"
The relative expression of IL - 1β, TNF - α, IL - 6, IL - 8, IL - 10, IL - 1α, IL - 17α and monocyte chemoattractant protein 1 ( MCP - 1) was determined by rt - PCR using the cDNA template and rhesus macaque - specific Taqman probes and primers ( Applied Biosystems, Foster City, CA ).	"IL - 1β	27	34	Gene/Protein"	"TNF - α	36	43	Gene/Protein"	"IL - 6	45	51	Gene/Protein"	"IL - 8	53	59	Gene/Protein"	"IL - 10	61	68	Gene/Protein"	"IL - 1α	70	77	Gene/Protein"	"IL - 17α	79	87	Gene/Protein"	"monocyte chemoattractant protein 1	92	126	Gene/Protein"	"MCP - 1	129	136	Gene/Protein"	"rhesus macaque	193	207	Organism/Species"	"[{""token"": ""IL - 1\u03b2"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b1"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17\u03b1"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""monocyte chemoattractant protein 1"", ""start_span"": 92, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 129, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""rhesus macaque"", ""start_span"": 193, ""end_span"": 207, ""type"": ""Organism/Species""}]"
The Wilcoxon test showed that the mean value of mercury for soil samples, 65. 8 ± 41. 7 ng g − 1 ( median 55. 6 ng g − 1 ), was statistically different from the mean values obtained for Tp and Ap bud samples ( IV ), and Tp leaf samples ( VI – XI ), but not statistically different from Ap leaf samples ( VI – XI) ( p = 0. 086) ( Table 3 ). Table 3Statistical summary of mercury concentrations ( ng g − 1) in the samplesSampleAverage ± S. D. MedianMinimumMaximumSoil ( IV – XI) 65. 8 ± 41. 755. 614. 5238. 9 Ap tree buds ( IV) 40. 8 ± 22. 736. 212. 498. 7 Ap leaves ( VI – IX) 50. 7 ± 15. 848. 023. 188. 7 Tp tree buds ( IV) 28. 2 ± 13. 626. 68. 059. 5 Tp leaves ( VI – IX) 55. 4 ± 18. 155. 426. 5106. 9	"Tp	186	188	Organism/Species"	"Ap	193	195	Organism/Species"	"Tp	220	222	Organism/Species"	"Ap	286	288	Organism/Species"	"Ap	507	509	Organism/Species"	"tree	510	514	Organism/Species"	"Ap	555	557	Organism/Species"	"Tp	605	607	Organism/Species"	"tree	608	612	Organism/Species"	"Tp	652	654	Organism/Species"	"[{""token"": ""Tp"", ""start_span"": 186, ""end_span"": 188, ""type"": ""Organism/Species""}, {""token"": ""Ap"", ""start_span"": 193, ""end_span"": 195, ""type"": ""Organism/Species""}, {""token"": ""Tp"", ""start_span"": 220, ""end_span"": 222, ""type"": ""Organism/Species""}, {""token"": ""Ap"", ""start_span"": 286, ""end_span"": 288, ""type"": ""Organism/Species""}, {""token"": ""Ap"", ""start_span"": 507, ""end_span"": 509, ""type"": ""Organism/Species""}, {""token"": ""tree"", ""start_span"": 510, ""end_span"": 514, ""type"": ""Organism/Species""}, {""token"": ""Ap"", ""start_span"": 555, ""end_span"": 557, ""type"": ""Organism/Species""}, {""token"": ""Tp"", ""start_span"": 605, ""end_span"": 607, ""type"": ""Organism/Species""}, {""token"": ""tree"", ""start_span"": 608, ""end_span"": 612, ""type"": ""Organism/Species""}, {""token"": ""Tp"", ""start_span"": 652, ""end_span"": 654, ""type"": ""Organism/Species""}]"
Table 1Baseline characteristics at diagnosisVariablePatients ( n = 87) Male sex, n (%) 71 ( 82) Age, median ( range) 63 ( 40 – 79) Non - clear cell pathology, n (%) 17 ( 20) WHO performance status, n (%) 0 – 182 ( 94) 2 – 45 ( 6) More than one metastatic site, n (%) 48 ( 55) Liver metastasis, n (%) 15 ( 17) Lung metastasis, n (%) 48 ( 56) Bone metastasis, n (%) 21 ( 24) Brain metastasis, n (%) 3 ( 3) Haemoglobin < LLN, n (%) 46 ( 52) Neutrophil count > ULN, n (%) 18 ( 21) Platelet count > ULN, n (%) 19 ( 22) Corrected serum calcium > ULN, n (%) 26 ( 30) Lactate dehydrogenase > 1. 5 times ULN, n (%) 11 ( 12) Time since RCC diagnosis < 1 year78 ( 90) MSKCC risk score, n (%) Favourable6 ( 7) Intermediate54 ( 62) Poor27 ( 31) LLN lower limit of normal, ULN upper limit of normal, RCC renal cell carcinoma, MSKCC Memorial Sloan Kettering Cancer Center	"Liver metastasis	276	292	Disease/Disorder"	"Lung metastasis	309	324	Disease/Disorder"	"Bone metastasis	341	356	Disease/Disorder"	"Brain metastasis	373	389	Disease/Disorder"	"Haemoglobin	404	415	Gene/Protein"	"Lactate dehydrogenase	560	581	Gene/Protein"	"RCC	626	629	Disease/Disorder"	"RCC	786	789	Disease/Disorder"	"renal cell carcinoma	790	810	Disease/Disorder"	"Cancer	843	849	Disease/Disorder"	"[{""token"": ""Liver metastasis"", ""start_span"": 276, ""end_span"": 292, ""type"": ""Disease/Disorder""}, {""token"": ""Lung metastasis"", ""start_span"": 309, ""end_span"": 324, ""type"": ""Disease/Disorder""}, {""token"": ""Bone metastasis"", ""start_span"": 341, ""end_span"": 356, ""type"": ""Disease/Disorder""}, {""token"": ""Brain metastasis"", ""start_span"": 373, ""end_span"": 389, ""type"": ""Disease/Disorder""}, {""token"": ""Haemoglobin"", ""start_span"": 404, ""end_span"": 415, ""type"": ""Gene/Protein""}, {""token"": ""Lactate dehydrogenase"", ""start_span"": 560, ""end_span"": 581, ""type"": ""Gene/Protein""}, {""token"": ""RCC"", ""start_span"": 626, ""end_span"": 629, ""type"": ""Disease/Disorder""}, {""token"": ""RCC"", ""start_span"": 786, ""end_span"": 789, ""type"": ""Disease/Disorder""}, {""token"": ""renal cell carcinoma"", ""start_span"": 790, ""end_span"": 810, ""type"": ""Disease/Disorder""}, {""token"": ""Cancer"", ""start_span"": 843, ""end_span"": 849, ""type"": ""Disease/Disorder""}]"
We observed a negative reciprocal interaction between AMPK activation and AT1R levels: metformin activated AMPK, annulling AngII - induced up - regulation of AT1R, whereas losartan ( AT1R antagonist) enhanced AMPK activation in AngII - treated H9c2 cardiomyocytes.	"AMPK	54	58	Gene/Protein"	"AT1R	74	78	Gene/Protein"	"metformin	87	96	Chemical/Drug"	"AMPK	107	111	Gene/Protein"	"AngII	123	128	Gene/Protein"	"AT1R	158	162	Gene/Protein"	"losartan	172	180	Chemical/Drug"	"AT1R	183	187	Gene/Protein"	"AMPK	209	213	Gene/Protein"	"AngII	228	233	Gene/Protein"	"[{""token"": ""AMPK"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""AT1R"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""metformin"", ""start_span"": 87, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""AMPK"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""AngII"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""AT1R"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""losartan"", ""start_span"": 172, ""end_span"": 180, ""type"": ""Chemical/Drug""}, {""token"": ""AT1R"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""AMPK"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""AngII"", ""start_span"": 228, ""end_span"": 233, ""type"": ""Gene/Protein""}]"
Matching sets of aliquots of plasma were analysed for target biomarkers namely, circulating endothelins, vascular endothelial growth factor ( VEGF) and other cardiovascular markers such as 8 - iso - PGF - 2α, matrix metalloproteinases ( MMPs) and acute phase proteins [ e. g ., C - reactive protein ( CRP ), cellular adhesion molecules ICAM - 1 and VCAM - 1 ].	"endothelins	92	103	Gene/Protein"	"vascular endothelial growth factor	105	139	Gene/Protein"	"VEGF	142	146	Gene/Protein"	"matrix metalloproteinases	209	234	Gene/Protein"	"MMPs	237	241	Gene/Protein"	"C - reactive protein	278	298	Gene/Protein"	"CRP	301	304	Gene/Protein"	"cellular adhesion molecules	308	335	Gene/Protein"	"ICAM - 1	336	344	Gene/Protein"	"VCAM - 1	349	357	Gene/Protein"	"[{""token"": ""endothelins"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 105, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""VEGF"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""matrix metalloproteinases"", ""start_span"": 209, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""MMPs"", ""start_span"": 237, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""C - reactive protein"", ""start_span"": 278, ""end_span"": 298, ""type"": ""Gene/Protein""}, {""token"": ""CRP"", ""start_span"": 301, ""end_span"": 304, ""type"": ""Gene/Protein""}, {""token"": ""cellular adhesion molecules"", ""start_span"": 308, ""end_span"": 335, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 336, ""end_span"": 344, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 349, ""end_span"": 357, ""type"": ""Gene/Protein""}]"
Analysis of maternal plasma samples for target markers, namely vascular endothelial growth factor ( VEGF - A ), acute phase proteins C - reactive protein ( CRP ), soluble intracellular adhesion molecule ( ICAM - 1 ), soluble vascular cell adhesion molecule ( VCAM - 1) and matrix metalloproteinases ( MMPs) were conducted by affinity - based multiplex protein array assays using Bio - Plex Pro Human panels ( Biorad, Mississauga, ON, Canada) and Milliplex Map kits ( Millipore, Bedford, MA ).	"vascular endothelial growth factor	63	97	Gene/Protein"	"VEGF - A	100	108	Gene/Protein"	"C - reactive protein	133	153	Gene/Protein"	"CRP	156	159	Gene/Protein"	"intracellular adhesion molecule	171	202	Gene/Protein"	"ICAM - 1	205	213	Gene/Protein"	"vascular cell adhesion molecule	225	256	Gene/Protein"	"VCAM - 1	259	267	Gene/Protein"	"matrix metalloproteinases	273	298	Gene/Protein"	"MMPs	301	305	Gene/Protein"	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 63, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""VEGF - A"", ""start_span"": 100, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""C - reactive protein"", ""start_span"": 133, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""CRP"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""intracellular adhesion molecule"", ""start_span"": 171, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""vascular cell adhesion molecule"", ""start_span"": 225, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 259, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""matrix metalloproteinases"", ""start_span"": 273, ""end_span"": 298, ""type"": ""Gene/Protein""}, {""token"": ""MMPs"", ""start_span"": 301, ""end_span"": 305, ""type"": ""Gene/Protein""}]"
Trypanosome lytic factor ( TLF) is a high - density lipoprotein ( HDL) subclass providing innate protection to humans against infection by the protozoan parasite Trypanosoma brucei brucei. Two primate - specific plasma proteins, haptoglobin - related protein ( Hpr) and apolipoprotein L - 1 ( ApoL - 1 ), have been proposed to kill T. b. brucei both singularly or when co - assembled into the same HDL.	"Trypanosome	0	11	Organism/Species"	"humans	111	117	Organism/Species"	"infection	126	135	Disease/Disorder"	"protozoan parasite	143	161	Organism/Species"	"Trypanosoma brucei brucei	162	187	Organism/Species"	"primate	193	200	Organism/Species"	"haptoglobin - related protein	229	258	Gene/Protein"	"Hpr	261	264	Gene/Protein"	"apolipoprotein L - 1	270	290	Gene/Protein"	"ApoL - 1	293	301	Gene/Protein"	"[{""token"": ""Trypanosome"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Organism/Species""}, {""token"": ""humans"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 126, ""end_span"": 135, ""type"": ""Disease/Disorder""}, {""token"": ""protozoan parasite"", ""start_span"": 143, ""end_span"": 161, ""type"": ""Organism/Species""}, {""token"": ""Trypanosoma brucei brucei"", ""start_span"": 162, ""end_span"": 187, ""type"": ""Organism/Species""}, {""token"": ""primate"", ""start_span"": 193, ""end_span"": 200, ""type"": ""Organism/Species""}, {""token"": ""haptoglobin - related protein"", ""start_span"": 229, ""end_span"": 258, ""type"": ""Gene/Protein""}, {""token"": ""Hpr"", ""start_span"": 261, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""apolipoprotein L - 1"", ""start_span"": 270, ""end_span"": 290, ""type"": ""Gene/Protein""}, {""token"": ""ApoL - 1"", ""start_span"": 293, ""end_span"": 301, ""type"": ""Gene/Protein""}]"
The three subspecies of Trypanosoma brucei are defined by their host range, geographical distribution, and course of disease [ 1 – 3 ]. Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense infect humans and cause African sleeping sickness, while Trypanosoma brucei brucei infects non - primate mammals and causes nagana in cattle.	"Trypanosoma brucei	24	42	Organism/Species"	"Trypanosoma brucei rhodesiense	136	166	Organism/Species"	"Trypanosoma brucei gambiense	171	199	Organism/Species"	"humans	207	213	Organism/Species"	"African sleeping sickness	224	249	Disease/Disorder"	"Trypanosoma brucei brucei	257	282	Organism/Species"	"primate	297	304	Organism/Species"	"mammals	305	312	Organism/Species"	"nagana	324	330	Disease/Disorder"	"cattle	334	340	Organism/Species"	"[{""token"": ""Trypanosoma brucei"", ""start_span"": 24, ""end_span"": 42, ""type"": ""Organism/Species""}, {""token"": ""Trypanosoma brucei rhodesiense"", ""start_span"": 136, ""end_span"": 166, ""type"": ""Organism/Species""}, {""token"": ""Trypanosoma brucei gambiense"", ""start_span"": 171, ""end_span"": 199, ""type"": ""Organism/Species""}, {""token"": ""humans"", ""start_span"": 207, ""end_span"": 213, ""type"": ""Organism/Species""}, {""token"": ""African sleeping sickness"", ""start_span"": 224, ""end_span"": 249, ""type"": ""Disease/Disorder""}, {""token"": ""Trypanosoma brucei brucei"", ""start_span"": 257, ""end_span"": 282, ""type"": ""Organism/Species""}, {""token"": ""primate"", ""start_span"": 297, ""end_span"": 304, ""type"": ""Organism/Species""}, {""token"": ""mammals"", ""start_span"": 305, ""end_span"": 312, ""type"": ""Organism/Species""}, {""token"": ""nagana"", ""start_span"": 324, ""end_span"": 330, ""type"": ""Disease/Disorder""}, {""token"": ""cattle"", ""start_span"": 334, ""end_span"": 340, ""type"": ""Organism/Species""}]"
Consistent with the recent finding that recombinant Hpr in complex with Hb does not bind the human Hp – Hb receptor CD163, the complex between native Hpr and Hb did not bind to immobilized purified human CD163 in the SPR analysis ( unpublished data) [ 31, 33 ].	"Hpr	52	55	Gene/Protein"	"Hb	72	74	Gene/Protein"	"human	93	98	Organism/Species"	"Hp	99	101	Gene/Protein"	"Hb	104	106	Gene/Protein"	"CD163	116	121	Gene/Protein"	"Hpr	150	153	Gene/Protein"	"Hb	158	160	Gene/Protein"	"human	198	203	Organism/Species"	"CD163	204	209	Gene/Protein"	"[{""token"": ""Hpr"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 72, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Organism/Species""}, {""token"": ""Hp"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""CD163"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Hpr"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 158, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 198, ""end_span"": 203, ""type"": ""Organism/Species""}, {""token"": ""CD163"", ""start_span"": 204, ""end_span"": 209, ""type"": ""Gene/Protein""}]"
MRC2 protein located in both cell membrane ( black arrow) and cytoplasm ( white arrow ); ( II) The representative IHC staining of MRC2 in adjacent liver tissues; ( III) The negative staining of MRC2 in HCC tissues; ( b) The western immunoblotting results of MRC2 in 3 pairs of representative HCC tissues ( T) and adjacent liver tissues ( N ); ( c) The IHC scores of MRC2 in HCC tissues were significantly higher than one in adjacent liver tissues ( p < 0. 001 ); and ( d) The comparison of Kaplan – Meier survival curves showed that patients with higher MRC2 expression in HCC tissues had worse prognosis after liver resection ( HR = 3. 071; 95% CI: 1. 357, 6. 951; p = 0. 007 ).	"MRC2	0	4	Gene/Protein"	"MRC2	130	134	Gene/Protein"	"MRC2	194	198	Gene/Protein"	"HCC	202	205	Disease/Disorder"	"MRC2	258	262	Gene/Protein"	"HCC	292	295	Disease/Disorder"	"MRC2	366	370	Gene/Protein"	"HCC	374	377	Disease/Disorder"	"MRC2	554	558	Gene/Protein"	"HCC	573	576	Disease/Disorder"	"[{""token"": ""MRC2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""MRC2"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""MRC2"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Disease/Disorder""}, {""token"": ""MRC2"", ""start_span"": 258, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 292, ""end_span"": 295, ""type"": ""Disease/Disorder""}, {""token"": ""MRC2"", ""start_span"": 366, ""end_span"": 370, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 374, ""end_span"": 377, ""type"": ""Disease/Disorder""}, {""token"": ""MRC2"", ""start_span"": 554, ""end_span"": 558, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 573, ""end_span"": 576, ""type"": ""Disease/Disorder""}]"
The expression of GFP, TaTypA :: GFP and TaTypA - N1 - 80 :: GFP proteins was determined by Western blot analysis using GFP antibody. The GFP antibody was diluted in blocking buffer at 1: 5000.	"GFP	18	21	Gene/Protein"	"TaTypA	23	29	Gene/Protein"	"GFP	33	36	Gene/Protein"	"TaTypA	41	47	Gene/Protein"	"GFP	61	64	Gene/Protein"	"GFP	120	123	Gene/Protein"	"antibody	124	132	Gene/Protein"	"GFP	138	141	Gene/Protein"	"antibody	142	150	Gene/Protein"	"at	182	184	Organism/Species"	"[{""token"": ""GFP"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""TaTypA"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""TaTypA"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 142, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""at"", ""start_span"": 182, ""end_span"": 184, ""type"": ""Organism/Species""}]"
CPD photolyases are found in organisms ranging from bacteria, fungi, plants and invertebrates to many vertebrates, while ( 6 – 4) photolyases occur in Drosophila, silkworms, frogs and rattlesnakes ( Sancar, 1996 ▶; Yasui et al ., 1994 ▶).	"CPD photolyases	0	15	Gene/Protein"	"bacteria	52	60	Organism/Species"	"fungi	62	67	Organism/Species"	"plants	69	75	Organism/Species"	"vertebrates	82	93	Organism/Species"	"photolyases	130	141	Gene/Protein"	"Drosophila	151	161	Organism/Species"	"silkworms	163	172	Organism/Species"	"frogs	174	179	Organism/Species"	"rattlesnakes	184	196	Organism/Species"	"[{""token"": ""CPD photolyases"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Organism/Species""}, {""token"": ""fungi"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Organism/Species""}, {""token"": ""vertebrates"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Organism/Species""}, {""token"": ""photolyases"", ""start_span"": 130, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""Drosophila"", ""start_span"": 151, ""end_span"": 161, ""type"": ""Organism/Species""}, {""token"": ""silkworms"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Organism/Species""}, {""token"": ""frogs"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Organism/Species""}, {""token"": ""rattlesnakes"", ""start_span"": 184, ""end_span"": 196, ""type"": ""Organism/Species""}]"
We transiently expressed HA - tagged PFN1 ( wt ), PFN1 ( S137A) or PFN1 ( S137D) in HEK293 cells along with Myc - PP1Cα, followed by immunoprecipitation of Myc - PP1Cα and Western blot for co - precipitation of HA - PFN1.	"HA	25	27	Gene/Protein"	"PFN1	37	41	Gene/Protein"	"PFN1	50	54	Gene/Protein"	"PFN1	67	71	Gene/Protein"	"Myc	108	111	Gene/Protein"	"PP1Cα	114	119	Gene/Protein"	"Myc	156	159	Gene/Protein"	"PP1Cα	162	167	Gene/Protein"	"HA	211	213	Gene/Protein"	"PFN1	216	220	Gene/Protein"	"[{""token"": ""HA"", ""start_span"": 25, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""Myc"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""PP1C\u03b1"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""Myc"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""PP1C\u03b1"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""HA"", ""start_span"": 211, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Gene/Protein""}]"
Free heart - shaped swim bladders were found in the families malapterurids ( electric catfishes ), heptapterids ( three - barbeled catfishes) and mochokids ( squeakers ), whereas bony encapsulated ones were found in the families loricariids ( armoured catfishes) and callichthyids ( callichthyid armoured catfishes) [ 19 ].	"malapterurids	61	74	Organism/Species"	"electric catfishes	77	95	Organism/Species"	"heptapterids	99	111	Organism/Species"	"three - barbeled catfishes	114	140	Organism/Species"	"mochokids	146	155	Organism/Species"	"squeakers	158	167	Organism/Species"	"loricariids	229	240	Organism/Species"	"armoured catfishes	243	261	Organism/Species"	"callichthyids	267	280	Organism/Species"	"callichthyid armoured catfishes	283	314	Organism/Species"	"[{""token"": ""malapterurids"", ""start_span"": 61, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""electric catfishes"", ""start_span"": 77, ""end_span"": 95, ""type"": ""Organism/Species""}, {""token"": ""heptapterids"", ""start_span"": 99, ""end_span"": 111, ""type"": ""Organism/Species""}, {""token"": ""three - barbeled catfishes"", ""start_span"": 114, ""end_span"": 140, ""type"": ""Organism/Species""}, {""token"": ""mochokids"", ""start_span"": 146, ""end_span"": 155, ""type"": ""Organism/Species""}, {""token"": ""squeakers"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Organism/Species""}, {""token"": ""loricariids"", ""start_span"": 229, ""end_span"": 240, ""type"": ""Organism/Species""}, {""token"": ""armoured catfishes"", ""start_span"": 243, ""end_span"": 261, ""type"": ""Organism/Species""}, {""token"": ""callichthyids"", ""start_span"": 267, ""end_span"": 280, ""type"": ""Organism/Species""}, {""token"": ""callichthyid armoured catfishes"", ""start_span"": 283, ""end_span"": 314, ""type"": ""Organism/Species""}]"
In Rad54 -/-/ Ptc1 +/- mice 14 genes were significantly downregulated ( 16. 7 %) and 8 upregulated ( 9. 5 %); in Parp - 1 -/-/ Ptc1 +/- mice, 22 genes were significantly downregulated ( 26 %) and 6 ( 7 %) upregulated; in Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/- mice, 10 genes ( 12 %) were downregulated and 16 ( 19 %) upregulated ( S1 Table ).	"Rad54	3	8	Gene/Protein"	"Ptc1	14	18	Gene/Protein"	"mice	23	27	Organism/Species"	"Parp - 1	113	121	Gene/Protein"	"Ptc1	127	131	Gene/Protein"	"mice	136	140	Organism/Species"	"Rad54	221	226	Gene/Protein"	"Parp - 1	232	240	Gene/Protein"	"Ptc1	246	250	Gene/Protein"	"mice	255	259	Organism/Species"	"[{""token"": ""Rad54"", ""start_span"": 3, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Organism/Species""}, {""token"": ""Parp - 1"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Organism/Species""}, {""token"": ""Rad54"", ""start_span"": 221, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 232, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 246, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 255, ""end_span"": 259, ""type"": ""Organism/Species""}]"
We validated Atm and Prkdc ( DNA - PKcs ), by RT - PCR confirming a significantly decreased expression in Rad54 and Parp - 1 compound mutants ( Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/-) compared to single mutants ( Figure 5C) and verified the decreased expression levels of ATM and DNA - PKcs by immunoblotting ( Figure 5D ).	"Atm	13	16	Gene/Protein"	"Prkdc	21	26	Gene/Protein"	"DNA - PKcs	29	39	Gene/Protein"	"Rad54	106	111	Gene/Protein"	"Parp - 1	116	124	Gene/Protein"	"Rad54	144	149	Gene/Protein"	"Parp - 1	155	163	Gene/Protein"	"Ptc1	169	173	Gene/Protein"	"ATM	267	270	Gene/Protein"	"DNA - PKcs	275	285	Gene/Protein"	"[{""token"": ""Atm"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""Prkdc"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""DNA - PKcs"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 155, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""ATM"", ""start_span"": 267, ""end_span"": 270, ""type"": ""Gene/Protein""}, {""token"": ""DNA - PKcs"", ""start_span"": 275, ""end_span"": 285, ""type"": ""Gene/Protein""}]"
Since evaluation of the effects of simultaneous Rad54 and Parp - 1 inactivation on MB development was prevented by the lack of viable compound mutants, we investigated the inactivation of DNA repair genes in the context of Ptc1 tumor suppression by examining mice with complete abrogation of either Rad54 or Parp - 1 function, in combination with heterozygosis of Parp - 1 or Rad54, respectively.	"Rad54	48	53	Gene/Protein"	"Parp - 1	58	66	Gene/Protein"	"MB	83	85	Disease/Disorder"	"Ptc1	223	227	Gene/Protein"	"tumor	228	233	Disease/Disorder"	"mice	259	263	Organism/Species"	"Rad54	299	304	Gene/Protein"	"Parp - 1	308	316	Gene/Protein"	"Parp - 1	364	372	Gene/Protein"	"Rad54	376	381	Gene/Protein"	"[{""token"": ""Rad54"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""MB"", ""start_span"": 83, ""end_span"": 85, ""type"": ""Disease/Disorder""}, {""token"": ""Ptc1"", ""start_span"": 223, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 228, ""end_span"": 233, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 259, ""end_span"": 263, ""type"": ""Organism/Species""}, {""token"": ""Rad54"", ""start_span"": 299, ""end_span"": 304, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 308, ""end_span"": 316, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 364, ""end_span"": 372, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 376, ""end_span"": 381, ""type"": ""Gene/Protein""}]"
Given the concurrent high levels of spontaneous DSBs in both Parp - 1 null mutants ( Parp - 1 -/-/ Ptc1 +/- and Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/-), the low apoptotic levels observed only in Parp - 1 -/-/ Ptc1 +/- correlate well with the high spontaneous rate of MB in these mice, and suggest that the cells can survive with a mutation in either repair pathways, not both, which causes cells to die.	"Parp - 1	61	69	Gene/Protein"	"Parp - 1	85	93	Gene/Protein"	"Ptc1	99	103	Gene/Protein"	"Rad54	112	117	Gene/Protein"	"Parp - 1	123	131	Gene/Protein"	"Ptc1	137	141	Gene/Protein"	"Parp - 1	190	198	Gene/Protein"	"Ptc1	204	208	Gene/Protein"	"MB	262	264	Disease/Disorder"	"mice	274	278	Organism/Species"	"[{""token"": ""Parp - 1"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 190, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""MB"", ""start_span"": 262, ""end_span"": 264, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 274, ""end_span"": 278, ""type"": ""Organism/Species""}]"
Due to their ecological and evolutionary importance, avian malaria parasites ( Plasmodium) and related haemosporidians ( Haemoproteus and Leucocytozoon ), the unicellular parasitic flagellate protozoa Trypanosoma, and the early stage in the life - cycle of some parasitic nematodes known as microfilaria, have become the focus of a number of avian studies and has resulted in the establishment of an open access database dedicated to haemosporidians ( MalAvi) [ 3, 16 – 23 ].	"avian malaria	53	66	Disease/Disorder"	"Plasmodium	79	89	Organism/Species"	"haemosporidians	103	118	Organism/Species"	"Haemoproteus	121	133	Organism/Species"	"Leucocytozoon	138	151	Organism/Species"	"protozoa	192	200	Organism/Species"	"Trypanosoma	201	212	Organism/Species"	"nematodes	272	281	Organism/Species"	"microfilaria	291	303	Organism/Species"	"haemosporidians	434	449	Organism/Species"	"[{""token"": ""avian malaria"", ""start_span"": 53, ""end_span"": 66, ""type"": ""Disease/Disorder""}, {""token"": ""Plasmodium"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Organism/Species""}, {""token"": ""haemosporidians"", ""start_span"": 103, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""Haemoproteus"", ""start_span"": 121, ""end_span"": 133, ""type"": ""Organism/Species""}, {""token"": ""Leucocytozoon"", ""start_span"": 138, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""protozoa"", ""start_span"": 192, ""end_span"": 200, ""type"": ""Organism/Species""}, {""token"": ""Trypanosoma"", ""start_span"": 201, ""end_span"": 212, ""type"": ""Organism/Species""}, {""token"": ""nematodes"", ""start_span"": 272, ""end_span"": 281, ""type"": ""Organism/Species""}, {""token"": ""microfilaria"", ""start_span"": 291, ""end_span"": 303, ""type"": ""Organism/Species""}, {""token"": ""haemosporidians"", ""start_span"": 434, ""end_span"": 449, ""type"": ""Organism/Species""}]"
Some bird species have been reported to be toxic, including the European quail ( Coturnix coturnix ), several New Guinea species from the genus Pitohui, the North - American ruffed grouse ( Bonasa umbellus ), the spur - winged goose ( Plectropterus gambensis) from Benin, and some Australian bronzewings from the genus Phaps [ 122 ].	"bird	5	9	Organism/Species"	"European quail	64	78	Organism/Species"	"Coturnix coturnix	81	98	Organism/Species"	"Pitohui	144	151	Organism/Species"	"ruffed grouse	174	187	Organism/Species"	"Bonasa umbellus	190	205	Organism/Species"	"spur - winged goose	213	232	Organism/Species"	"Plectropterus gambensis	235	258	Organism/Species"	"Australian bronzewings	281	303	Organism/Species"	"Phaps	319	324	Organism/Species"	"[{""token"": ""bird"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Organism/Species""}, {""token"": ""European quail"", ""start_span"": 64, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""Coturnix coturnix"", ""start_span"": 81, ""end_span"": 98, ""type"": ""Organism/Species""}, {""token"": ""Pitohui"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""ruffed grouse"", ""start_span"": 174, ""end_span"": 187, ""type"": ""Organism/Species""}, {""token"": ""Bonasa umbellus"", ""start_span"": 190, ""end_span"": 205, ""type"": ""Organism/Species""}, {""token"": ""spur - winged goose"", ""start_span"": 213, ""end_span"": 232, ""type"": ""Organism/Species""}, {""token"": ""Plectropterus gambensis"", ""start_span"": 235, ""end_span"": 258, ""type"": ""Organism/Species""}, {""token"": ""Australian bronzewings"", ""start_span"": 281, ""end_span"": 303, ""type"": ""Organism/Species""}, {""token"": ""Phaps"", ""start_span"": 319, ""end_span"": 324, ""type"": ""Organism/Species""}]"
Those six plans were derived from the following abduced facts: icpea ( pmek, s_1_erk1, s_1_perk1, sb203580, decrease) icpea ( pmek, s_1_erk2, s_1_perk2, sb203580, decrease) icria ( fsh, r_pmek, sb203580, decrease) icelisa ( fsh, a_pmek, sb203580, decrease) pa ( pp38mapk, mek, a_pmek, increase) icppa ( fsh, mek, a_pmek, sb203580, decrease)	"sb203580	98	106	Chemical/Drug"	"sb203580	153	161	Chemical/Drug"	"fsh	181	184	Gene/Protein"	"sb203580	194	202	Chemical/Drug"	"fsh	224	227	Gene/Protein"	"sb203580	237	245	Chemical/Drug"	"mek	272	275	Gene/Protein"	"fsh	303	306	Gene/Protein"	"mek	308	311	Gene/Protein"	"sb203580	321	329	Chemical/Drug"	"[{""token"": ""sb203580"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""sb203580"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Chemical/Drug""}, {""token"": ""fsh"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""sb203580"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Chemical/Drug""}, {""token"": ""fsh"", ""start_span"": 224, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""sb203580"", ""start_span"": 237, ""end_span"": 245, ""type"": ""Chemical/Drug""}, {""token"": ""mek"", ""start_span"": 272, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""fsh"", ""start_span"": 303, ""end_span"": 306, ""type"": ""Gene/Protein""}, {""token"": ""mek"", ""start_span"": 308, ""end_span"": 311, ""type"": ""Gene/Protein""}, {""token"": ""sb203580"", ""start_span"": 321, ""end_span"": 329, ""type"": ""Chemical/Drug""}]"
Interestingly, many highly abundant proteins related to sugar - and carbohydrate metabolism, such as Tdh1, Tdh2, Adh1, Tpi1, Pgk1 and also Cdc19 were found in a genome wide SILAC approach to be significantly undertranslated in S. cerevisiae cells lacking uba4 or ncs2 [ 36, 37 ].	"sugar	56	61	Chemical/Drug"	"carbohydrate	68	80	Chemical/Drug"	"Tdh1	101	105	Gene/Protein"	"Tdh2	107	111	Gene/Protein"	"Adh1	113	117	Gene/Protein"	"Tpi1	119	123	Gene/Protein"	"Pgk1	125	129	Gene/Protein"	"Cdc19	139	144	Gene/Protein"	"uba4	255	259	Gene/Protein"	"ncs2	263	267	Gene/Protein"	"[{""token"": ""sugar"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""carbohydrate"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""Tdh1"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Tdh2"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""Adh1"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Tpi1"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""Pgk1"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""Cdc19"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""uba4"", ""start_span"": 255, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""ncs2"", ""start_span"": 263, ""end_span"": 267, ""type"": ""Gene/Protein""}]"
Participants completed questionnaires and underwent comprehensive medical examinations including liver ultrasound, anthropometric measurements, and blood analysis to measure markers for liver function and injury, including alanine transaminase ( ALT ), aspartate aminotransferase ( AST ), alkaline phosphatase ( ALP ), gama - glutamyltransferase ( GGT ), and albumin ( ALB ).	"alanine transaminase	223	243	Gene/Protein"	"ALT	246	249	Gene/Protein"	"aspartate aminotransferase	253	279	Gene/Protein"	"AST	282	285	Gene/Protein"	"alkaline phosphatase	289	309	Gene/Protein"	"ALP	312	315	Gene/Protein"	"gama - glutamyltransferase	319	345	Gene/Protein"	"GGT	348	351	Gene/Protein"	"albumin	359	366	Gene/Protein"	"ALB	369	372	Gene/Protein"	"[{""token"": ""alanine transaminase"", ""start_span"": 223, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""ALT"", ""start_span"": 246, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""aspartate aminotransferase"", ""start_span"": 253, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""AST"", ""start_span"": 282, ""end_span"": 285, ""type"": ""Gene/Protein""}, {""token"": ""alkaline phosphatase"", ""start_span"": 289, ""end_span"": 309, ""type"": ""Gene/Protein""}, {""token"": ""ALP"", ""start_span"": 312, ""end_span"": 315, ""type"": ""Gene/Protein""}, {""token"": ""gama - glutamyltransferase"", ""start_span"": 319, ""end_span"": 345, ""type"": ""Gene/Protein""}, {""token"": ""GGT"", ""start_span"": 348, ""end_span"": 351, ""type"": ""Gene/Protein""}, {""token"": ""albumin"", ""start_span"": 359, ""end_span"": 366, ""type"": ""Gene/Protein""}, {""token"": ""ALB"", ""start_span"": 369, ""end_span"": 372, ""type"": ""Gene/Protein""}]"
We then excluded HCV core Ag negative ( HCV core Ag < 3fmol / L) or anti - HCV positive patients without viremia ( HCV RNA viral negative ); 88 and 42 patients were included in the HCV mono - infection and co - infection groups, respectively ( Table 3 ).	"HCV	17	20	Organism/Species"	"core Ag	21	28	Gene/Protein"	"HCV	40	43	Organism/Species"	"core Ag	44	51	Gene/Protein"	"HCV	75	78	Organism/Species"	"viremia	105	112	Disease/Disorder"	"HCV	115	118	Organism/Species"	"HCV	181	184	Organism/Species"	"infection	192	201	Disease/Disorder"	"co - infection	206	220	Disease/Disorder"	"[{""token"": ""HCV"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Organism/Species""}, {""token"": ""core Ag"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""HCV"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Organism/Species""}, {""token"": ""core Ag"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""HCV"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""viremia"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Disease/Disorder""}, {""token"": ""HCV"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 192, ""end_span"": 201, ""type"": ""Disease/Disorder""}, {""token"": ""co - infection"", ""start_span"": 206, ""end_span"": 220, ""type"": ""Disease/Disorder""}]"
There percentage of HCV core Ag - positive patients in the HCV RNA - negative / HBV - HCV co - infection group was significantly lower than in the HCV RNA - positive / HBV - HCV co - infection group ( 28. 0% versus 73. 68 %, P < 0. 0001) ( Table 4 ).	"HCV	20	23	Organism/Species"	"core Ag	24	31	Gene/Protein"	"HCV	59	62	Organism/Species"	"HBV	80	83	Organism/Species"	"HCV	86	89	Organism/Species"	"co - infection	90	104	Disease/Disorder"	"HCV	147	150	Organism/Species"	"HBV	168	171	Organism/Species"	"HCV	174	177	Organism/Species"	"co - infection	178	192	Disease/Disorder"	"[{""token"": ""HCV"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Organism/Species""}, {""token"": ""core Ag"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""HCV"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 90, ""end_span"": 104, ""type"": ""Disease/Disorder""}, {""token"": ""HCV"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 178, ""end_span"": 192, ""type"": ""Disease/Disorder""}]"
The HBV - HCV co - infection group had higher ALT, AST, ALP, GGT, APRI and FIB - 4 levels, but lower ALB and total platelet compared to the HBV mono - infection group ( Table 1 ).	"HBV	4	7	Organism/Species"	"HCV	10	13	Organism/Species"	"co - infection	14	28	Disease/Disorder"	"ALT	46	49	Gene/Protein"	"AST	51	54	Gene/Protein"	"ALP	56	59	Gene/Protein"	"GGT	61	64	Gene/Protein"	"ALB	101	104	Gene/Protein"	"HBV	140	143	Organism/Species"	"infection	151	160	Disease/Disorder"	"[{""token"": ""HBV"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 14, ""end_span"": 28, ""type"": ""Disease/Disorder""}, {""token"": ""ALT"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""AST"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""ALP"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""GGT"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""ALB"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""HBV"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Disease/Disorder""}]"
The Bdellovibrio genome has, in addition to the bd0097bd0099 groES groEL genes, a second homologue, bd3349, of groES ( here designated groES2 versus groES1 for bd0097 ), so we investigated the expression of all these genes by RT - PCR using matched amounts of RNA from wild - type and sigma - factor mutant Bdellovibrio, treated in attack phase, at different temperatures ( 29 ° C and heat - shock 42 ° C for 10 mins; Figure 3) using methods previously described [ 15 ].	"Bdellovibrio	4	16	Organism/Species"	"groES	61	66	Gene/Protein"	"groEL	67	72	Gene/Protein"	"bd3349	100	106	Gene/Protein"	"groES	111	116	Gene/Protein"	"groES2	135	141	Gene/Protein"	"groES1	149	155	Gene/Protein"	"bd0097	160	166	Gene/Protein"	"sigma - factor	285	299	Gene/Protein"	"Bdellovibrio	307	319	Organism/Species"	"[{""token"": ""Bdellovibrio"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Organism/Species""}, {""token"": ""groES"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""groEL"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""bd3349"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""groES"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""groES2"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""groES1"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""bd0097"", ""start_span"": 160, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""sigma - factor"", ""start_span"": 285, ""end_span"": 299, ""type"": ""Gene/Protein""}, {""token"": ""Bdellovibrio"", ""start_span"": 307, ""end_span"": 319, ""type"": ""Organism/Species""}]"
Then cells were fixed and neutralising antibody was detected with goat anti - mouse rhodamine antibody ( red) and rabbit antibody against EEA - 1, and detected using Alexa Fluor 647 - conjugated donkey anti - rabbit ( blue ).	"antibody	39	47	Gene/Protein"	"goat	66	70	Organism/Species"	"mouse	78	83	Organism/Species"	"rhodamine	84	93	Chemical/Drug"	"antibody	94	102	Gene/Protein"	"rabbit	114	120	Organism/Species"	"antibody	121	129	Gene/Protein"	"EEA - 1	138	145	Gene/Protein"	"donkey	195	201	Organism/Species"	"rabbit	209	215	Organism/Species"	"[{""token"": ""antibody"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Organism/Species""}, {""token"": ""rhodamine"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""antibody"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Organism/Species""}, {""token"": ""antibody"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""EEA - 1"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""donkey"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Organism/Species""}]"
Abbreviations: N = number;% = percent; CI = confidence interval; OME = otitis media with effusion; AOM / woP = acute otitis media without perforation; AOM / wiP = acute otitis media with perforation; CSOM = chronic suppurative otitis media; OM = otitis media.	"OME	65	68	Disease/Disorder"	"otitis media with effusion	71	97	Disease/Disorder"	"AOM	99	102	Disease/Disorder"	"acute otitis media	111	129	Disease/Disorder"	"AOM	151	154	Disease/Disorder"	"acute otitis media	163	181	Disease/Disorder"	"CSOM	200	204	Disease/Disorder"	"chronic suppurative otitis media	207	239	Disease/Disorder"	"OM	241	243	Disease/Disorder"	"otitis media	246	258	Disease/Disorder"	"[{""token"": ""OME"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Disease/Disorder""}, {""token"": ""otitis media with effusion"", ""start_span"": 71, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""AOM"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Disease/Disorder""}, {""token"": ""acute otitis media"", ""start_span"": 111, ""end_span"": 129, ""type"": ""Disease/Disorder""}, {""token"": ""AOM"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Disease/Disorder""}, {""token"": ""acute otitis media"", ""start_span"": 163, ""end_span"": 181, ""type"": ""Disease/Disorder""}, {""token"": ""CSOM"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Disease/Disorder""}, {""token"": ""chronic suppurative otitis media"", ""start_span"": 207, ""end_span"": 239, ""type"": ""Disease/Disorder""}, {""token"": ""OM"", ""start_span"": 241, ""end_span"": 243, ""type"": ""Disease/Disorder""}, {""token"": ""otitis media"", ""start_span"": 246, ""end_span"": 258, ""type"": ""Disease/Disorder""}]"
Three main classes of antiplatelet agents are licensed for treatment of atherothrombosis: acetyl salicylic acid ( aspirin ), P2Y12 inhibitors ( ticlopidine, clopidogrel, prasugrel, cangrelor, ticagrelor ), and GpIIb / Ilia receptor antagonists ( abciximab, eptifibatide, and tirofiban) ( 11 ).	"aspirin	114	121	Chemical/Drug"	"P2Y12	125	130	Gene/Protein"	"ticlopidine	144	155	Chemical/Drug"	"clopidogrel	157	168	Chemical/Drug"	"prasugrel	170	179	Chemical/Drug"	"cangrelor	181	190	Chemical/Drug"	"ticagrelor	192	202	Chemical/Drug"	"GpIIb / Ilia receptor	210	231	Gene/Protein"	"eptifibatide	257	269	Chemical/Drug"	"tirofiban	275	284	Chemical/Drug"	"[{""token"": ""aspirin"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""P2Y12"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""ticlopidine"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""clopidogrel"", ""start_span"": 157, ""end_span"": 168, ""type"": ""Chemical/Drug""}, {""token"": ""prasugrel"", ""start_span"": 170, ""end_span"": 179, ""type"": ""Chemical/Drug""}, {""token"": ""cangrelor"", ""start_span"": 181, ""end_span"": 190, ""type"": ""Chemical/Drug""}, {""token"": ""ticagrelor"", ""start_span"": 192, ""end_span"": 202, ""type"": ""Chemical/Drug""}, {""token"": ""GpIIb / Ilia receptor"", ""start_span"": 210, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""eptifibatide"", ""start_span"": 257, ""end_span"": 269, ""type"": ""Chemical/Drug""}, {""token"": ""tirofiban"", ""start_span"": 275, ""end_span"": 284, ""type"": ""Chemical/Drug""}]"
For phospho - Trk and phospho - Erk activation, CGN and PC12 cells were incubated in serum - free DME supplemented with 0. 1% bovine serum albumin ( BSA) and 2mM L - glutamine and 100μg / ml penicillin and 100μg / ml streptomycin ( DMEB) for 1h prior to treatment with BDNF, proBDNF and HBpF - proBDNF.	"Trk	14	17	Gene/Protein"	"Erk	32	35	Gene/Protein"	"albumin	139	146	Gene/Protein"	"BSA	149	152	Gene/Protein"	"L - glutamine	162	175	Chemical/Drug"	"penicillin	191	201	Chemical/Drug"	"streptomycin	217	229	Chemical/Drug"	"BDNF	269	273	Gene/Protein"	"proBDNF	275	282	Gene/Protein"	"proBDNF	294	301	Gene/Protein"	"[{""token"": ""Trk"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""Erk"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""albumin"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""BSA"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""L - glutamine"", ""start_span"": 162, ""end_span"": 175, ""type"": ""Chemical/Drug""}, {""token"": ""penicillin"", ""start_span"": 191, ""end_span"": 201, ""type"": ""Chemical/Drug""}, {""token"": ""streptomycin"", ""start_span"": 217, ""end_span"": 229, ""type"": ""Chemical/Drug""}, {""token"": ""BDNF"", ""start_span"": 269, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""proBDNF"", ""start_span"": 275, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""proBDNF"", ""start_span"": 294, ""end_span"": 301, ""type"": ""Gene/Protein""}]"
To confirm that HBpF - proBDNF does not activate TrkB, we exposed CGNs to mBDNF ( 25ng / ml ), to commercial proBDNF ( 2 and 25ng / ml ), and to HBpF - proBDNF ( 2 and 25ng / ml) for 30 min and then performed immunoblots for phospho - TrkB and total TrkB. Fig 5A shows that mBDNF induces robust TrkB phosphorylation whereas commercial proBDNF and HBpF - proBDNF had no effect on TrkB phosphorylation.	"proBDNF	23	30	Gene/Protein"	"TrkB	49	53	Gene/Protein"	"proBDNF	109	116	Gene/Protein"	"proBDNF	152	159	Gene/Protein"	"TrkB	235	239	Gene/Protein"	"TrkB	250	254	Gene/Protein"	"TrkB	295	299	Gene/Protein"	"proBDNF	335	342	Gene/Protein"	"proBDNF	354	361	Gene/Protein"	"TrkB	379	383	Gene/Protein"	"[{""token"": ""proBDNF"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""TrkB"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""proBDNF"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""proBDNF"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""TrkB"", ""start_span"": 235, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""TrkB"", ""start_span"": 250, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""TrkB"", ""start_span"": 295, ""end_span"": 299, ""type"": ""Gene/Protein""}, {""token"": ""proBDNF"", ""start_span"": 335, ""end_span"": 342, ""type"": ""Gene/Protein""}, {""token"": ""proBDNF"", ""start_span"": 354, ""end_span"": 361, ""type"": ""Gene/Protein""}, {""token"": ""TrkB"", ""start_span"": 379, ""end_span"": 383, ""type"": ""Gene/Protein""}]"
( C) The mean percentage of viral capture of HIV by erythrocytes with or without inhibition with soluble gp120 is plotted in individuals who present IgG anti - gp120 in erythrocytes (+ IgG anti - gp120 - E, line with square) and in individuals who do not present IgG anti - gp120 in erythrocytes (- IgG anti - gp120 - E, line with rhomb ).	"HIV	45	48	Organism/Species"	"gp120	105	110	Gene/Protein"	"IgG	149	152	Gene/Protein"	"gp120	160	165	Gene/Protein"	"IgG	185	188	Gene/Protein"	"gp120	196	201	Gene/Protein"	"IgG	263	266	Gene/Protein"	"gp120	274	279	Gene/Protein"	"IgG	299	302	Gene/Protein"	"gp120	310	315	Gene/Protein"	"[{""token"": ""HIV"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Organism/Species""}, {""token"": ""gp120"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""gp120"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""gp120"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 263, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""gp120"", ""start_span"": 274, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 299, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""gp120"", ""start_span"": 310, ""end_span"": 315, ""type"": ""Gene/Protein""}]"
These cells were positive for CD166, CD73, CD105, CD90, CD44, weak positive expression for KDR, and negative for CD117, CD34, CD45 and Cadherin V.	"CD166	30	35	Gene/Protein"	"CD73	37	41	Gene/Protein"	"CD105	43	48	Gene/Protein"	"CD90	50	54	Gene/Protein"	"CD44	56	60	Gene/Protein"	"KDR	91	94	Gene/Protein"	"CD117	113	118	Gene/Protein"	"CD34	120	124	Gene/Protein"	"CD45	126	130	Gene/Protein"	"Cadherin V	135	145	Gene/Protein"	"[{""token"": ""CD166"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""CD73"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""CD105"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""CD90"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""CD44"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""KDR"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CD117"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""CD34"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""CD45"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Cadherin V"", ""start_span"": 135, ""end_span"": 145, ""type"": ""Gene/Protein""}]"
Several ookinete proteins, such as the surface proteins P25 / P28 ( Siden - Kiamos et al ., 2000 ), secreted ookinete adhesive protein ( SOAP) ( Dessens et al ., 2003 ), circumsporozoite - and TRAP - related protein ( CTRP) ( Dessens et al ., 1999) and von Willebrand factor A domain - related - protein ( WARP) ( Yuda et al ., 2001 ), that are reportedly essential for ookinete and oocyst development in vivo, have been shown to bind to BL components such as laminin and collagen ( Adini and Warburg, 1999; Arrighi et al ., 2005 ).	"surface proteins P25	39	59	Gene/Protein"	"P28	62	65	Gene/Protein"	"secreted ookinete adhesive protein	100	134	Gene/Protein"	"SOAP	137	141	Gene/Protein"	"circumsporozoite - and TRAP - related protein	170	215	Gene/Protein"	"CTRP	218	222	Gene/Protein"	"von Willebrand factor A domain - related - protein	253	303	Gene/Protein"	"WARP	306	310	Gene/Protein"	"laminin	460	467	Gene/Protein"	"collagen	472	480	Gene/Protein"	"[{""token"": ""surface proteins P25"", ""start_span"": 39, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""P28"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""secreted ookinete adhesive protein"", ""start_span"": 100, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""SOAP"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""circumsporozoite - and TRAP - related protein"", ""start_span"": 170, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""CTRP"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""von Willebrand factor A domain - related - protein"", ""start_span"": 253, ""end_span"": 303, ""type"": ""Gene/Protein""}, {""token"": ""WARP"", ""start_span"": 306, ""end_span"": 310, ""type"": ""Gene/Protein""}, {""token"": ""laminin"", ""start_span"": 460, ""end_span"": 467, ""type"": ""Gene/Protein""}, {""token"": ""collagen"", ""start_span"": 472, ""end_span"": 480, ""type"": ""Gene/Protein""}]"
In the rumen of cattle, ubiquitous detected genera include Clostridium, Bacteroides, Succinivibrio, Prevotella and Ruminococcus ( Dowd et al ., 2008; Callaway et al ., 2010 ). Fibrobacter, formerly grouped to Bacteroides, as well as Ruminococcus and uncultured bacteria have also been suggested to play important roles in cellulose hydrolysis in the rumen ( Leschine, 1995; Ransom - Jones et al ., 2012 ).	"cattle	16	22	Organism/Species"	"Clostridium	59	70	Organism/Species"	"Bacteroides	72	83	Organism/Species"	"Succinivibrio	85	98	Organism/Species"	"Prevotella	100	110	Organism/Species"	"Ruminococcus	115	127	Organism/Species"	"Fibrobacter	176	187	Organism/Species"	"Bacteroides	209	220	Organism/Species"	"Ruminococcus	233	245	Organism/Species"	"bacteria	261	269	Organism/Species"	"[{""token"": ""cattle"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Organism/Species""}, {""token"": ""Clostridium"", ""start_span"": 59, ""end_span"": 70, ""type"": ""Organism/Species""}, {""token"": ""Bacteroides"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Organism/Species""}, {""token"": ""Succinivibrio"", ""start_span"": 85, ""end_span"": 98, ""type"": ""Organism/Species""}, {""token"": ""Prevotella"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Organism/Species""}, {""token"": ""Ruminococcus"", ""start_span"": 115, ""end_span"": 127, ""type"": ""Organism/Species""}, {""token"": ""Fibrobacter"", ""start_span"": 176, ""end_span"": 187, ""type"": ""Organism/Species""}, {""token"": ""Bacteroides"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Organism/Species""}, {""token"": ""Ruminococcus"", ""start_span"": 233, ""end_span"": 245, ""type"": ""Organism/Species""}, {""token"": ""bacteria"", ""start_span"": 261, ""end_span"": 269, ""type"": ""Organism/Species""}]"
In addition, sequences belonging to Acidobacteria, Actinobacteria, Chloroflexi, Fibrobacteres, Planctomycetes, Proteobacteria, Synergistetes, Tenericutes, Thermi and Verrucomicrobia were detected in some of the samples, but at low occurrence ( below 3. 3% for each sample ).	"Acidobacteria	36	49	Organism/Species"	"Actinobacteria	51	65	Organism/Species"	"Chloroflexi	67	78	Organism/Species"	"Fibrobacteres	80	93	Organism/Species"	"Planctomycetes	95	109	Organism/Species"	"Proteobacteria	111	125	Organism/Species"	"Synergistetes	127	140	Organism/Species"	"Tenericutes	142	153	Organism/Species"	"Thermi	155	161	Organism/Species"	"Verrucomicrobia	166	181	Organism/Species"	"[{""token"": ""Acidobacteria"", ""start_span"": 36, ""end_span"": 49, ""type"": ""Organism/Species""}, {""token"": ""Actinobacteria"", ""start_span"": 51, ""end_span"": 65, ""type"": ""Organism/Species""}, {""token"": ""Chloroflexi"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""Fibrobacteres"", ""start_span"": 80, ""end_span"": 93, ""type"": ""Organism/Species""}, {""token"": ""Planctomycetes"", ""start_span"": 95, ""end_span"": 109, ""type"": ""Organism/Species""}, {""token"": ""Proteobacteria"", ""start_span"": 111, ""end_span"": 125, ""type"": ""Organism/Species""}, {""token"": ""Synergistetes"", ""start_span"": 127, ""end_span"": 140, ""type"": ""Organism/Species""}, {""token"": ""Tenericutes"", ""start_span"": 142, ""end_span"": 153, ""type"": ""Organism/Species""}, {""token"": ""Thermi"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Organism/Species""}, {""token"": ""Verrucomicrobia"", ""start_span"": 166, ""end_span"": 181, ""type"": ""Organism/Species""}]"
Secondary antibodies such as Alexa 488 - conjugated anti - mouse or anti - rabbit antibody ( A11017; A11070; 1: 200 dilution; Invitrogen, Eugene, OR ), Texas Red - conjugated anti - mouse, anti - rabbit, or anti - rat antibody ( TI - 2000; TI - 1000; TI - 9400; 1: 200 dilution; Vector Labs, Burlingame, CA ), or Cy5 - conjugated anti - mouse or anti - rabbit antibody ( A10524; A10523; 1: 200 dilution; Invitrogen) were treated at room temperature for 40 min.	"mouse	59	64	Organism/Species"	"rabbit	75	81	Organism/Species"	"mouse	182	187	Organism/Species"	"rabbit	196	202	Organism/Species"	"rat	214	217	Organism/Species"	"TI -	229	233	Chemical/Drug"	"TI - 1000	240	249	Chemical/Drug"	"TI - 9400	251	260	Chemical/Drug"	"mouse	337	342	Organism/Species"	"rabbit	353	359	Organism/Species"	"[{""token"": ""mouse"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 182, ""end_span"": 187, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Organism/Species""}, {""token"": ""rat"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Organism/Species""}, {""token"": ""TI -"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Chemical/Drug""}, {""token"": ""TI - 1000"", ""start_span"": 240, ""end_span"": 249, ""type"": ""Chemical/Drug""}, {""token"": ""TI - 9400"", ""start_span"": 251, ""end_span"": 260, ""type"": ""Chemical/Drug""}, {""token"": ""mouse"", ""start_span"": 337, ""end_span"": 342, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 353, ""end_span"": 359, ""type"": ""Organism/Species""}]"
Table 1Index characteristics and family history by mutation status ( n = 734) Mutation negative,% ( n) Mutation positive,% ( n) P valuen65183Revised Bethesda guidelines76% ( 494) 90% ( 75) 0. 003Index characteristics Male gender47% ( 305) 49% ( 41) 0. 66 CRC Age CRC ( median, IQR) 53 years [ 45 – 62] 49 years [ 39 – 59] 0. 002 Proximal CRC28% ( 185) 64% ( 53 )< 0. 001 ≥ 2 CRCs10% ( 66) 21% ( 17) 0. 005 Endometrial cancer3% ( 11) 41% ( 17 )< 0. 001 Age EC ( median, IQR) 55 years [ 50 – 75] 54 years [ 49 – 57] 0. 18 Multiple LS cancers4% ( 27) 13% ( 11) 0. 002First degree relatives CRC55% ( 358) 51% ( 42) 0. 45 ≥ 2 FDRs with CRC16% ( 107) 17% ( 14) 0. 92 Age CRC ( median, IQR) 64 years [ 55 – 71] 50 years [ 43 – 57 ]< 0. 001 Endometrial cancer5% ( 35) 19% ( 16 )< 0. 001 ≥ 2 FDRs with EC0. 6% ( 4) 2% ( 2) 0. 14 Age EC ( median, IQR) 55 years [ 50 – 64] 50 years [ 45 – 57] 0. 25 Other LS cancers22% ( 142) 19% ( 16) 0. 60Second degree relatives CRC33% ( 212) 35% ( 29) 0. 66 ≥ 2 SDRs with CRC12% ( 81) 12% ( 10) 0. 92 Age CRC ( median, IQR) 62 years [ 50 – 74] 47 years [ 38 – 64] 0. 008 Endometrial cancer3% ( 22) 7% ( 6) 0. 12 ≥ 2 SDRs with EC0. 3% ( 2) 2% ( 2) 0. 07 Age EC ( median, IQR) 70 years [ 50 – 76] 49 years [ 44 – 51] 0. 13 Other LS cancers16% ( 104) 18% ( 15) 0. 63	"CRC	255	258	Disease/Disorder"	"CRC	263	266	Disease/Disorder"	"EC	456	458	Disease/Disorder"	"LS	529	531	Disease/Disorder"	"CRC	587	590	Disease/Disorder"	"EC	793	795	Disease/Disorder"	"LS	894	896	Disease/Disorder"	"CRC	954	957	Disease/Disorder"	"EC	1152	1154	Disease/Disorder"	"LS	1253	1255	Disease/Disorder"	"[{""token"": ""CRC"", ""start_span"": 255, ""end_span"": 258, ""type"": ""Disease/Disorder""}, {""token"": ""CRC"", ""start_span"": 263, ""end_span"": 266, ""type"": ""Disease/Disorder""}, {""token"": ""EC"", ""start_span"": 456, ""end_span"": 458, ""type"": ""Disease/Disorder""}, {""token"": ""LS"", ""start_span"": 529, ""end_span"": 531, ""type"": ""Disease/Disorder""}, {""token"": ""CRC"", ""start_span"": 587, ""end_span"": 590, ""type"": ""Disease/Disorder""}, {""token"": ""EC"", ""start_span"": 793, ""end_span"": 795, ""type"": ""Disease/Disorder""}, {""token"": ""LS"", ""start_span"": 894, ""end_span"": 896, ""type"": ""Disease/Disorder""}, {""token"": ""CRC"", ""start_span"": 954, ""end_span"": 957, ""type"": ""Disease/Disorder""}, {""token"": ""EC"", ""start_span"": 1152, ""end_span"": 1154, ""type"": ""Disease/Disorder""}, {""token"": ""LS"", ""start_span"": 1253, ""end_span"": 1255, ""type"": ""Disease/Disorder""}]"
Carpel identity is specified by at least two separate pathways: one is mediated by the class C gene AGAMOUS ( AG) 8, and class E or SEPALLATA genes, as described in the expanded ABC model9; the second is an AG - independent pathway involving SPT and CRC genes10, both of which are negatively regulated by class A genes11, such as APETALA2 ( AP2) and LEUNIG ( LUG) 121314.	"AGAMOUS	100	107	Gene/Protein"	"AG	110	112	Gene/Protein"	"SEPALLATA	132	141	Gene/Protein"	"AG	207	209	Gene/Protein"	"SPT	242	245	Gene/Protein"	"CRC	250	253	Gene/Protein"	"APETALA2	330	338	Gene/Protein"	"AP2	341	344	Gene/Protein"	"LEUNIG	350	356	Gene/Protein"	"LUG	359	362	Gene/Protein"	"[{""token"": ""AGAMOUS"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""AG"", ""start_span"": 110, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""SEPALLATA"", ""start_span"": 132, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""AG"", ""start_span"": 207, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""SPT"", ""start_span"": 242, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""CRC"", ""start_span"": 250, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""APETALA2"", ""start_span"": 330, ""end_span"": 338, ""type"": ""Gene/Protein""}, {""token"": ""AP2"", ""start_span"": 341, ""end_span"": 344, ""type"": ""Gene/Protein""}, {""token"": ""LEUNIG"", ""start_span"": 350, ""end_span"": 356, ""type"": ""Gene/Protein""}, {""token"": ""LUG"", ""start_span"": 359, ""end_span"": 362, ""type"": ""Gene/Protein""}]"
The mRNA expression of proinflammatory cytokines such as IL - 15, IL - 18, IL - 1β and IFNγ, chemokines such as MCP1 and CXCL2 and anti - and pro - apoptotic molecules as Bcl - 2 and Bax respectively, were analyzed, but no changes were observed ( data not shown ).	"cytokines	39	48	Gene/Protein"	"IL - 15	57	64	Gene/Protein"	"IL - 18	66	73	Gene/Protein"	"IL - 1β	75	82	Gene/Protein"	"IFNγ	87	91	Gene/Protein"	"chemokines	93	103	Gene/Protein"	"MCP1	112	116	Gene/Protein"	"CXCL2	121	126	Gene/Protein"	"Bcl - 2	171	178	Gene/Protein"	"Bax	183	186	Gene/Protein"	"[{""token"": ""cytokines"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""IL - 18"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IFN\u03b3"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""chemokines"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""MCP1"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""CXCL2"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""Bax"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene/Protein""}]"
Since tumors in a K14cre - driven variant of this model were highly sensitive to a combination of cisplatin and the PARP - inhibitor olaparib [ 14 ], we tested both prophylactic monotherapies and the combination of ID cisplatin and olaparib in the whey acidic protein ( WAP) cre - driven tumor model.	"tumors	6	12	Disease/Disorder"	"cisplatin	98	107	Chemical/Drug"	"PARP	116	120	Gene/Protein"	"olaparib	133	141	Chemical/Drug"	"cisplatin	218	227	Chemical/Drug"	"olaparib	232	240	Chemical/Drug"	"whey acidic protein	248	267	Gene/Protein"	"WAP	270	273	Gene/Protein"	"cre	275	278	Gene/Protein"	"tumor	288	293	Disease/Disorder"	"[{""token"": ""tumors"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Disease/Disorder""}, {""token"": ""cisplatin"", ""start_span"": 98, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""PARP"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""olaparib"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Chemical/Drug""}, {""token"": ""cisplatin"", ""start_span"": 218, ""end_span"": 227, ""type"": ""Chemical/Drug""}, {""token"": ""olaparib"", ""start_span"": 232, ""end_span"": 240, ""type"": ""Chemical/Drug""}, {""token"": ""whey acidic protein"", ""start_span"": 248, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""WAP"", ""start_span"": 270, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""cre"", ""start_span"": 275, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 288, ""end_span"": 293, ""type"": ""Disease/Disorder""}]"
The RNA of whole blood from 60 AA SLE patients, 47 anti - RBP antibody positive ( RBP +), and 13 anti - RBP antibody negative ( RBP −), and 56 EA SLE patients, 21 RBP + and 24 RBP − along with 25 AA and 8 EA controls was purified using Qiagen RNeasy kit.	"SLE	34	37	Disease/Disorder"	"RBP	58	61	Gene/Protein"	"antibody	62	70	Gene/Protein"	"RBP	82	85	Gene/Protein"	"RBP	104	107	Gene/Protein"	"antibody	108	116	Gene/Protein"	"RBP	128	131	Gene/Protein"	"SLE	146	149	Disease/Disorder"	"RBP	163	166	Gene/Protein"	"RBP	176	179	Gene/Protein"	"[{""token"": ""SLE"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Disease/Disorder""}, {""token"": ""RBP"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""SLE"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Disease/Disorder""}, {""token"": ""RBP"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}]"
IPA, ingenuity pathway analysis; IFN, interferon; SLE, systemic lupus erythematosus; EA, European - American; AA, African - American; IRF, interferon - regulatory factor; RIG1, retinoic acid - inducible gene 1; and PKR, protein kinase R.	"IFN	33	36	Gene/Protein"	"interferon	38	48	Gene/Protein"	"SLE	50	53	Disease/Disorder"	"systemic lupus erythematosus	55	83	Disease/Disorder"	"IRF	134	137	Gene/Protein"	"interferon - regulatory factor	139	169	Gene/Protein"	"RIG1	171	175	Gene/Protein"	"retinoic acid - inducible gene 1	177	209	Gene/Protein"	"PKR	215	218	Gene/Protein"	"protein kinase R	220	236	Gene/Protein"	"[{""token"": ""IFN"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""interferon"", ""start_span"": 38, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""SLE"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Disease/Disorder""}, {""token"": ""systemic lupus erythematosus"", ""start_span"": 55, ""end_span"": 83, ""type"": ""Disease/Disorder""}, {""token"": ""IRF"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""interferon - regulatory factor"", ""start_span"": 139, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""RIG1"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid - inducible gene 1"", ""start_span"": 177, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""PKR"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase R"", ""start_span"": 220, ""end_span"": 236, ""type"": ""Gene/Protein""}]"
IFN - γ or rapamycin treatment significantly increased median bacterial co - localization with p62 in CF human MDMs ( CF IFN - γ 32. 7% ( 25. 2 – 33. 4 ), p = 0. 006, CF rapamycin 26. 3% ( 22. 4 – 47. 4 ), p = 0. 008, Figures 2A, B) nearing non - CF levels.	"IFN - γ	0	7	Gene/Protein"	"rapamycin	11	20	Chemical/Drug"	"p62	95	98	Gene/Protein"	"CF	102	104	Disease/Disorder"	"human	105	110	Organism/Species"	"CF	118	120	Disease/Disorder"	"IFN - γ	121	128	Gene/Protein"	"CF	167	169	Disease/Disorder"	"rapamycin	170	179	Chemical/Drug"	"CF	247	249	Disease/Disorder"	"[{""token"": ""IFN - \u03b3"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""rapamycin"", ""start_span"": 11, ""end_span"": 20, ""type"": ""Chemical/Drug""}, {""token"": ""p62"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 102, ""end_span"": 104, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Organism/Species""}, {""token"": ""CF"", ""start_span"": 118, ""end_span"": 120, ""type"": ""Disease/Disorder""}, {""token"": ""IFN - \u03b3"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 167, ""end_span"": 169, ""type"": ""Disease/Disorder""}, {""token"": ""rapamycin"", ""start_span"": 170, ""end_span"": 179, ""type"": ""Chemical/Drug""}, {""token"": ""CF"", ""start_span"": 247, ""end_span"": 249, ""type"": ""Disease/Disorder""}]"
Upon the homology - based principle of this method, seven plant species were selected as templates, based on one of the three criteria ( the model plant, Arabidopsis, has abundant PPI information; potato, rice and maize are starch - storing crops; castor bean, poplar and soybean are closely related to cassava ).	"plant	58	63	Organism/Species"	"plant	147	152	Organism/Species"	"Arabidopsis	154	165	Organism/Species"	"potato	197	203	Organism/Species"	"rice	205	209	Organism/Species"	"maize	214	219	Organism/Species"	"castor bean	248	259	Organism/Species"	"poplar	261	267	Organism/Species"	"soybean	272	279	Organism/Species"	"cassava	303	310	Organism/Species"	"[{""token"": ""plant"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Organism/Species""}, {""token"": ""Arabidopsis"", ""start_span"": 154, ""end_span"": 165, ""type"": ""Organism/Species""}, {""token"": ""potato"", ""start_span"": 197, ""end_span"": 203, ""type"": ""Organism/Species""}, {""token"": ""rice"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Organism/Species""}, {""token"": ""maize"", ""start_span"": 214, ""end_span"": 219, ""type"": ""Organism/Species""}, {""token"": ""castor bean"", ""start_span"": 248, ""end_span"": 259, ""type"": ""Organism/Species""}, {""token"": ""poplar"", ""start_span"": 261, ""end_span"": 267, ""type"": ""Organism/Species""}, {""token"": ""soybean"", ""start_span"": 272, ""end_span"": 279, ""type"": ""Organism/Species""}, {""token"": ""cassava"", ""start_span"": 303, ""end_span"": 310, ""type"": ""Organism/Species""}]"
Hypomorphic Apc mice ( Apcfl / fl) were previously shown to develop HCC with activation of the Wnt / β - catenin pathway ( nuclear localisation of β - catenin and activation of Wnt - related genes ). 26 To assess T - UCRs downstream of the Wnt pathway, we profiled ncRNA expression by microarray in the liver of Apcfl / fl and control Apc +/+ mice.	"Apc	12	15	Gene/Protein"	"mice	16	20	Organism/Species"	"HCC	68	71	Disease/Disorder"	"Wnt	95	98	Gene/Protein"	"β - catenin	101	112	Gene/Protein"	"β - catenin	147	158	Gene/Protein"	"Wnt	177	180	Gene/Protein"	"Wnt	240	243	Gene/Protein"	"Apc	312	315	Gene/Protein"	"mice	343	347	Organism/Species"	"[{""token"": ""Apc"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Organism/Species""}, {""token"": ""HCC"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Disease/Disorder""}, {""token"": ""Wnt"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 147, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""Apc"", ""start_span"": 312, ""end_span"": 315, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 343, ""end_span"": 347, ""type"": ""Organism/Species""}]"
Expression of uc. 158 −, uc. 455 +, uc. 196 + and uc. 82 − was assessed by real - time PCR in the liver tissues of a second series of Apcfl / fl and control Apc +/+ mice ( figure 1B ). uc. 158 − and uc. 455 + were confirmed to be significantly upregulated and downregulated, respectively, in Wnt - dependent HCC. uc. 158 − is an intergenic 224 nt long UCR located on chromosome 13 in the mouse and on chromosome 5 in the human genome. uc. 455 + is a 245 nt long UCR located on chromosome 2 in the mouse and on chromosome 20 in the human genome, where it overlaps in antisense the RNA - binding protein motif 39 ( RBPM39) gene.	"Apc	134	137	Gene/Protein"	"mice	165	169	Organism/Species"	"Wnt	292	295	Gene/Protein"	"HCC	308	311	Disease/Disorder"	"mouse	388	393	Organism/Species"	"human	421	426	Organism/Species"	"mouse	497	502	Organism/Species"	"human	531	536	Organism/Species"	"RNA - binding protein motif 39	580	610	Gene/Protein"	"RBPM39	613	619	Gene/Protein"	"[{""token"": ""Apc"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Organism/Species""}, {""token"": ""Wnt"", ""start_span"": 292, ""end_span"": 295, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 308, ""end_span"": 311, ""type"": ""Disease/Disorder""}, {""token"": ""mouse"", ""start_span"": 388, ""end_span"": 393, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 421, ""end_span"": 426, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 497, ""end_span"": 502, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 531, ""end_span"": 536, ""type"": ""Organism/Species""}, {""token"": ""RNA - binding protein motif 39"", ""start_span"": 580, ""end_span"": 610, ""type"": ""Gene/Protein""}, {""token"": ""RBPM39"", ""start_span"": 613, ""end_span"": 619, ""type"": ""Gene/Protein""}]"
